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BOOTH, ROBERT ARTHUR, JR., Ph.D. The Relationship of Blood Pressure, 
Calcium, and Exercise in Normotensive Women. (1990) 
Directed by: Dr. Helen Shaw. 136 pp. 
This study assessed possible relationships between exercise, blood calcium, 
and blood pressure in women. Serum total calcium (STCa), serum ionized calcium 
(SICa), platelet ionized calcium (PCa), and blood pressure were compared in 
trained (n=20) and untrained (n=21) normotensive women (18-40 yrs.). Serum 
sodium, potassium, magnesium (SMg), albumin (SAlb), and total protein (STpro), 
plus dietary intakes of total calories, calcium, protein, fat, and carbohydrate were 
also measured. Training was defined as running at least 20 miles/week for the six 
months prior to the study, with untrained defined as less than 10 miles/week. 
Three blood pressure measurements were obtained from fasted subjects in 
the supine position, after a ten minute stabilization period, utilizing a Dinamap vital 
signs monitor. A blood sample for analysis of the serum parameters and PCa was 
taken after the blood pressure measurements. Subjects were asked to keep a 
seven-day food record which was analyzed with the Nutripractor 6000 dietary 
analysis software package. 
Resting heart rate (HR), mean arterial blood pressure (MAP), and diastolic 
blood pressure (DBP) were significantly lower in the trained than in the untrained 
women (p=0.0005, p=0.023, and p=0.001, respectively). ANCOVA adjustment for 
HR removed the significance in MAP but not DBP between the groups. SMg, 
STpro, SAlb, STCa, and PCa levels were significantly higher in the trained than in 
the untrained group, while SICa levels were significantly lower. ANCOVA 
adjustment of the blood calcium parameters for SAlb concentration removed the 
significant difference for STCa and PCa levels between the groups but not SICa. 
No associations were observed between calcium indices and blood pressure; 
however, SAlb was negatively correlated with DBP (r= -0.35, p=0.02), and SICa 
(r= -0.54, p=0.0003), and positively correlated with STCa (r=0.53, p=0.0004), and 
PCa (r=0.50, p=0.0009). The trained women had a higher caloric intake resulting 
primarily from higher protein and carbohydrate intakes, and a higher calcium 
intake, than the untrained group. Dietary total calcium did not correlate with either 
blood pressure or any of the blood calcium parameters. 
The results of this study suggest that the hypotensive effect of training is not 
related to alterations in either blood calcium parameters or to dietary calcium. The 
results further confirmed that training increased SAlb and STpro concentrations and 
altered calcium binding kinetics within the various blood calcium fractions. The 
significant relationships between SAlb and all of the blood calcium parameters and 
between SAlb and DBP suggest a role for SAlb in blood pressure regulation. 
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CHAPTER I 
INTRODUCTION 
Cardiovascular disease reportedly accounts for more than 50 percent of 
all deaths in the United States (Gotto, 1986). Research from clinical and 
epidemiological studies on cardiovascular morbidity and mortality has indicated 
that smoking, hypertension, and hypercholesterolemia are the three primary risk 
factors in the development of the disease. The identification of these risk 
factors has prompted the treatment of cardiovascular disease through risk factor 
intervention. 
Epidemiological studies observing the association between blood 
pressure, morbidity, and mortality suggest that resting pressure is a major 
indicator for cardiovascular morbidity and mortality (Fagard et al., 1990). This 
research supports the earlier assessment of the Framingham study that of the 
three primary risk factors, hypertension is the most prevalent contributor to 
cardiovascular morbidity and mortality (Kannel, 1975). Data from the 
Framingham Study (Kannel, 1975) suggest that hypertensives in the 45-74 age 
range have approximately a three-fold greater chance of developing coronary 
heart disease, a four-fold greater chance of congestive heart failure, and suffer 
seven times as many strokes as their normotensive counterparts. Hypertensive 
health care costs account for approximately ten to twelve percent of the 
estimated eighty billion dollar annual national health care costs associated with 
cardiovascular disease (The 1988 Joint National Committee, 1988). 
2 
Hypertension is traditionally defined as a systolic/diastolic pressure 
reading of 160/95 mm Hg or above, with borderline hypertension identified as a 
reading between 140/90 -160/95 mm Hg. It has been estimated that 
approximately sixty million Americans are either hypertensive or borderline 
hypertensive (The 1988 Joint National Committee, 1988). 
Although great advances have been made in the treatment and 
understanding of hypertension in the past fifteen years, it is still not possible to 
discuss the mechanisms involved in its development with a high degree of 
certainty. Only secondary hypertension, which accounts for between five to ten 
percent of all hypertension cases, has known causes. Since so many systems 
are involved in the regulation of vascular tension and vary between acute, 
intermediate, and long-term control, it can reasonably be assumed that there is 
no one single cause of hypertension. Alterations in plasma volume, renal 
function, cardiac output, peripheral resistance, the renin-angiotensin system, 
and intra- and extracellular cation levels all play a role in vascular tension, 
making blood pressure regulation highly complex and sometimes confusing. 
Whatever alterations there are in the pressure mechanisms, the effect is 
normally a change in the contractile state of the vascular smooth muscle. 
Changes in electrical activity of the sarcolemma and the interaction of agents 
with membrane receptors alter the permeability of the membrane, which alters 
the intracellular concentration of various cations. Alterations in the cellular 
mechanisms which regulate cytosolic cation concentrations may therefore 
contribute to abnormal vascular tension observed in various hypertensive states. 
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Ionic abnormalities, involving mainly sodium and calcium, have been well 
documented in hypertensive animal and human subjects (Erne, Bolli, Burgisser, 
& Buhler, 1984; Folsom, Smith, Prineas, & Grimm, 1986; Le Quan Sang & 
Devynck, 1986; McCarron, 1982; Postnov & Orlov, 1984). While alterations in 
sodium handling initially received the most attention, research in the past 
decade has identified an association between sodium sensitivity and cellular 
calcium handling (Stoy,1988). This has led to the proposal that alterations in 
cell membrane function result in abnormal cellular calcium handling and 
subsequent alterations in blood pressure (Postnov & Orlov, 1984). This 
proposal is supported by the fact that any physiological changes resulting in 
either an increased influx of ionized calcium from the extracellular medium, or a 
decreased efflux of calcium ions from vascular smooth muscle cells will lead to 
an increased cytosolic free calcium and increased vascular tension (Rubin, 
1970). Thus, treatment for hypertension resulting from ionic abnormalities must 
be geared to the restoration of ionic balance both intra- and extracellularly. 
The two principal approaches to hypertensive treatment are 
pharmacologic therapy (also called anti-hypertensive drug therapy), and 
nonpharmacologic therapy, which includes such interventions as weight 
reduction, sodium restriction, dietary potassium and calcium manipulation, 
relaxation, and exercise. Applications of the current knowledge of differences in 
calcium parameters in relation to blood pressure are present in the use of 
pharmacological therapies such as beta-blockers, which block the activation of 
receptor operated channels, and calcium-channel blockers, which block the 
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influx of ionized calcium into the cytosoi (Lees & Reid, 1990). Calcium channel 
blockade results in a decreased influx of extracellular ionized calcium, 
decreased cytosolic ionized calcium, and decreased blood pressure. While the 
effectiveness of anti-hypertensive drugs in reducing blood pressure has been 
well established, recent evidence suggests that their efficacy may be enhanced, 
and some side effects mitigated when combined with nonpharmacologic 
treatments (Kaplan, 1984). 
Exercise training has proven useful in blood pressure reduction in both 
hypertensive and normotensive subjects (Duncan et al., 1985; Kiyonaga, 
Arakawa, Tanaka, & Shindo, 1985; Saar, Chayoth, & Meyerstein, 1986; Seals & 
Hagberg, 1984). It has been suggested that the decreases in blood pressure 
observed with aerobic exercise training are consequences of a decrease in 
peripheral vascular resistance, possibly due to a decrease in peripheral 
sympathetic tone (Saar et al., 1986). Although changes in sympathetic nervous 
system activity have been suggested, only a few studies have assessed 
changes in blood parameters associated with exercise training. Two studies 
have observed decreased plasma catecholamine levels with exercise training 
(Duncan et al., 1985; Kiyonaga et al., 1985), while another observed no change 
in concentration despite a significant reduction in blood pressure (Seals & 
Hagberg, 1984). Increased plasma prostaglandin E2 levels, decreased plasma 
insulin levels, and increased urinary excretion of sodium have also been 
observed with exercise training (Kiyonaga et al., 1985). While some of these 
changes may be associated with a decrease in sympathetic tone, no 
5 
mechanism has yet been identified as being responsible for effecting these 
changes. Peripherally circulating catecholamines and other vasoactive 
substances affect the permeability of various cell membranes allowing 
alterations in ionic fluxes across them (Nishizuka, 1989). The alteration of extra-
and intracellular ionic calcium concentrations play a critical role in muscular 
contraction, in the release of catecholamines from adrenergic nerves, and in 
vascular tension (Rubin, 1970). If changes in blood pressure observed with 
exercise training are due to a peripheral effect of altered concentrations of 
vasoactive substances or membrane sensitivity to them, changes in the serum 
and/or cellular calcium parameters should correlate with changes in blood 
pressure. Current research, however, is limited in the assessment of a possible 
relationship between exercise training and blood calcium parameters and its 
correlation with blood pressure. 
Since chronic aerobic exercise appears to have a beneficial blood 
pressure lowering effect and alterations in smooth muscle cytosolic calcium 
concentrations appear to correlate with changes in vascular tension, there may 
be an effect of exercise on the permeability of the smooth muscle membrane 
affecting cellular calcium handling. The purpose of this study, therefore, was to 
assess whether differences exist in resting blood calcium parameters, 
specifically serum total calcium, serum ionized calcium, and platelet ionized 
calcium, between trained (defined as running a minimum of 20 miles/week for at 
least six months prior) and untrained (defined as running less than 10 
miles/week for at least six months prior) normotensive premenopausal females, 
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and if a significant relationship existed between these parameters and blood 
pressure. Additional parameters (serum albumin, total protein, magnesium, 
sodium, and potassium concentrations) were assessed to determine if there 
were significant differences between the trained and untrained subjects and if 
these parameters might be associated with possible changes in blood calcium 
parameters. 
The following hypotheses were proposed: 
H1: Mean arterial pressures (MAP) for the trained group will be significantly 
lower (p < 0.05) than for the untrained group. 
H2: There will be a mean difference of at least 2 mm Hg diastolic and 5 mm Hg 
systolic between trained and untrained subjects. 
H3: Serum ionized calcium concentration will be significantly greater (p < 0.05) 
in the trained vs. untrained group. 
H4: Platelet ionized calcium concentration will be significantly lower (p < 0.05) 
in the trained vs. untrained group. 
H5: Serum total calcium and albumin modified serum total calcium 
concentrations will not be significantly different (p > 0.05) between the two 
groups. 
H6: Serum magnesium, sodium, and potassium will not be significantly different 
(p > 0.05) between the two groups. 
H7: There will be a significant positive relationship between platelet ionized 
calcium and diastolic, systolic, and mean arterial pressures. 
H8: There will be a significant positive relationship between serum albumin and 
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diastolic, systolic, and mean arterial pressures. 
H9: There will be a significant inverse relationship between serum ionized 
calcium and diastolic, systolic, and mean arterial pressures. 
H10: There will be a significant inverse relationship between dietary calcium 
intake and diastolic, systolic, and mean arterial pressures. 
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CHAPTER II 
REVIEW OF LITERATURE 
Blood Pressure Regulation 
The pressure of the blood as it flows through the vasculature is 
determined by the nature of the blood (volume, viscosity, etc.), the heart (stroke 
volume and cardiac output), and the resistance in the vessels. The nature of 
the blood will only affect pressure when its viscosity changes, which rarely 
happens in humans, except with polycythemia, hyperglobulinemia, or 
macroglobulinemia (Guyton, 1980). The effect of the heart and vascular 
resistance on blood pressure is mediated by the factors of cardiac output, blood 
volume, arterial wall elasticity, and peripheral resistance. These factors interact 
to regulate blood pressure at rest and in response to internal and external 
influences such as changes in temperature, physical or emotional stress, and 
the metabolic demands of the body. 
Regulation of the factors affecting blood pressure is accomplished 
through intrinsic and extrinsic control processes. The intrinsic process, called 
autoregulation, is a system of mechanisms which directly alter arterial diameters 
in response to local tissue needs. The mechanisms involved in this process are 
stress relaxation, which enables blood vessels to gradually dialate in response 
to increasing blood pressure, and capillary fluid shift, which moves plasma 
between the vessels and the extravascular compartments (Guyton, 1980). The 
intrinsic process of autoregulation is one of many non-neural processes involved 
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in arterial pressure regulation. Mechanical and chemical, rather than nervous, 
stimulation of stretch receptors in the vascular tissue is the force behind 
autoregulatory induced vascular relaxation (Burnstock & Griffith, 1988; Guyton, 
1980). In most tissues of the body the requirement for oxygen appears to be 
the most important initiator of autoregulatory vasodilation, with other nutrients 
such as glucose, amino acids, and vitamins playing a minor role (Burnstock & 
Griffith, 1988; Guyton, 1980). Locally released non-neural vasodilators which 
may be related to the autoregulatory process include histamine from mast cells, 
bradykinin, prostaglandins, and leukotrienes (Burnstock & Griffith, 1988). 
Adaptations in the autoregulatory process develop over a period of weeks, 
months, or possibly longer, resulting in a fine tuning of the blood flow to meet 
the needs of the vascular tissue (Guyton, 1980), and a possible contributing 
mechanism in chronic pressure regulation. 
Extrinsic control processes, so called because they are initiated outside 
the circulatory system, regulate cardiac output, peripheral resistance, and blood 
volume through a complex, highly coordinated process of central nervous 
system and endocrine responses, called the neuroendocrine response. This 
response involves centrally located centers in the brain stem, hypothalamus, 
and spinal cord which regulate the responses of the heart and peripheral 
vasculature to maintain cardiovascular homeostasis. 
To maintain this continuous control of arterial pressure the body has 
developed a hierarchy of controls. Intrinsic and extrinsic pressure control 
systems can be grouped into three major categories based on their reaction 
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time and duration of effect. Acute mechanisms, which react and dissipate 
rapidly, are primarily cardiovascular reflexes, such as the carotid baroreceptors, 
mediated by the nervous system (Guyton, 1980). Intermediate mechanisms, 
which are slower to react and more sustained than acute mechanisms, include 
the autoregulatory mechanisms of stress relaxation and capillary fluid shifts. 
Both acute and intermediate mechanisms, however, are not capable of returning 
the arterial pressure to its baseline levels following pressure changes, their 
primary function being pressure buffering rather than establishing baseline 
pressure (Guyton, 1980). 
Guyton (1980) suggested that the systems that maintain baseline blood 
pressure are those which regulate blood volume (i.e. the kidneys) and vascular 
tone. The primary importance of acute and intermediate control mechanisms is 
in their response to the external effects on arterial pressure. The mechanisms 
which mediate long-term pressure control seem to be the most important in 
chronic hypertension, and are also those about which the least is known 
(Guyton, 1980). 
The aim of this review is to provide a general overview of the roles played 
by the central nervous system, autonomic nervous system, and the primary 
cardiovascular organs involved in blood pressure homeostasis. Particular 
attention will be given to the ionic alterations in vascular smooth muscle relating 
to changes in blood pressure, and to the effect of exercise training on blood 
pressure. 
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Nervous Control of Blood Pressure 
Central Nervous System Regulation. 
The control of cardiovascular function is maintained by mechanical, 
chemical, and neural mechanisms whose contribution to circulatory regulation 
varies in different vascular beds. The global task of integrating these regulatory 
mechanisms to ensure that all cardiovascular functions are adjusted according 
to the current circulatory situation rests with the central nervous system. While 
the role of the central nervous system in the moment-to-moment control of 
arterial pressure is fairly well accepted, its role in chronic regulation is less clear. 
The medulla area of the brain stem is the primary region that influences 
the cardiovascular system. Nuclei in this region are connected to regions in the 
spinal cord, the hypothalamus, and the cardiovascular organs, providing a 
highly complex, central control network for the maintenance of cardiovascular 
homeostasis. Information is transmitted back and forth along this network by 
means of chemical messengers such as catecholamines, opioid and other 
neuropeptides, and by direct electrical stimulation. 
Regulatory centers in the brain stem rely on the input they receive from 
the periphery for the current state of cardiovascular function. Baroreceptors, 
primarily involved in acute regulation mechanisms, sense changes in blood 
pressure and relay the information to the nucleus tractus solitarius in the dorsal 
medulla, which is the primary site of termination for impulses from all arterial and 
cardiopulmonary baroreceptor afferent neurons (Wyss, Oparil, & Chen, 1990). 
The neurotransmitters released from these baroreceptor afferent neurons at the 
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nucleus tractus solitarius have not been firmly identified. Studies involving 
microinjections of epinephrine, norepinephrine, dopamine and other adrenergic 
agonists into the region of the nucleus tractus solitarius have been shown to 
result in bradycardia and arterial hypotension similar to that observed with 
baroreceptor activation (Guthrie & Kotchen, 1984) .The stimulated nucleus 
tractus solitarius, in turn, stimulates sympathetic preganglionic neurons 
projecting to the paraventricular nucleus of the hypothalamus, where it modifys 
the activity of vasopressin-releasing neuron projections to the pituitary, and 
inhibits parasympathetic neurons to the heart, resulting in an increased heart 
rate (Wyss et al., 1990). Other areas of the medulla also stimulated by the 
nucleus tractus solitarius include the dorsal motor nucleus of the vagus, the 
nucleus ambiguus, the ventrolateral medulla, and the area postrema. 
Innervation of the neurons in the dorsal motor nucleus of the vagus and the 
nucleus ambiguus results in increased parasympathetic stimulation of the heart. 
The nucleus ambiguus region appears to be the major center of 
parasympathetic depressor projections to the heart (Wyss et al., 1990). The 
importance of the nucleus tractus solitarius in blood pressure regulation was 
demonstrated by Dampney and Moon (1980), whose experiments showed that 
lesions in the nucleus tractus solitarius of laboratory animals results in 
hypertension. 
Immediately dorsal to the nucleus tractus solitarius is the area postrema, 
which also receives messages from the peripheral baroreceptors. Its 
uniqueness lies in its lack of a blood-brain barrier, which allows it to react to 
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peripherally circulating vasoactive substances such as angiotensin II (Wyss et 
al., 1990). This addition of peripheral activation to the signals being relayed to 
the nucleus tractus solitarius results in a more comprehensive control of 
vasomotor sympathetic activity and a more intergrated control of arterial 
pressure. 
The two areas of the ventrolateral medulla involved in cardiovascular 
pressure regulation are the C1 and A1 areas (Wyss et al., 1990). C1 neurons 
project to sympathetic autonomic nuclei in the spinal cord. Stimulation of C1 
neurons results in significant increases in heart rate and blood pressure, release 
of adrenomedullary catecholamines, and release of the vasoconstrictor 
vasopressin from the posterior pituitary (Wyss et al., 1990). C1 neurons may 
play a role in the long-term regulation of blood pressure through their action on 
the sympathetic nervous system. It has been suggested that these neurons 
maintain background input to the vasomotor centers in the spinal cord, thereby 
continuously regulating sympathetic nervous control of arterial pressure (Wyss 
et al., 1990). 
The A1 area of the ventrolateral medulla contains noradrenergic neurons, 
stimulation of which inhibits sympathetic discharge and lowers blood pressure 
(Imaizumi, Granata, Benarroch, Sved, & Reis, 1985). In contrast to the C1 area, 
release of norepinephrine from stimulated A1 neurons seems to have an 
inhibitory effect on tonic vasomotor neurons (Imaizumi et al., 1985). 
Although the medulla appears to contain the majority of the centers 
involved in the regulation of arterial pressure, other brain stem areas also play a 
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role. Signals from the nucleus tractus solitarius and the hypothalamus stimulate 
the parabrachial nucleus of the pons producing an increase in heart rate and a 
rise in arterial pressure (Mraovitch, Kamada, & Reis, 1982). The periaqueductal 
region of the midbrain also appears to have a role, as yet unspecified, in 
cardiovascular regulation (Wyss et al., 1990). 
Autonomic Nervous System Regulation. 
The spinal cord contains the autonomic nervous link between the 
cardiovascular regulatory centers in the brain and the peripheral vascular 
system. The information received in the brain centers on the current 
cardiovascular situation is intergrated and transmitted to various areas of the 
cardiovascular system via the autonomic nervous system. The autonomic 
nervous system regulates cardiac output, blood volume and composition, and 
blood pressure through dual antagonistic innervation of its two efferent divisions, 
the sympathetic and parasympathetic nervous systems. Both systems 
commonly act on all cardiovascular organs, but produce opposite responses. 
Vasoconstrictor activity is normally associated with the sympathetic nervous 
system and vasodilator activity is normally associated with the parasympathetic 
system (Clark, Queener, & Karb, 1982). Thus, the activity of cardiovascular 
organs is the result of the stimulation of two opposing systems directed by the 
regulatory systems in the brain and the hypothalamus. 
The common pathway for brain center regulation of sympathetic nervous 
activity is through the preganglionic neurons in lamina seven of the thoracic 
spinal cord, with most of the neurons located in the intermediolateral cell column 
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(Guthrie & Kotchen, 1984; Wyss et al., 1990). The activity of these neurons is 
controlled by direct sensory innervation from the periphery and via descending 
projections from the regulatory centers in the brain. 
Information from the regulatory centers in the brain passed along 
autonomic neurons to the appropriate cardiovascular organs is mediated by the 
release of neurotransmitters from the neurons. Norepinephrine, the 
predominant neurotransmitter released from sympathetic neurons, has an 
intense vasoconstrictor effect upon arterial smooth muscle, mediated primarily 
by alpha-1 (AJ receptors on the vascular membrane (Burnstock & Griffith, 
1988). Other acute hemodynamic effects of sympathetic stimulation include 
stimulation of the heart, an increased pre- to postcapillary resistance ratio, and 
venous constriction (Guyton, 1980). Sympathetic stimulation also indirectly 
contributes to peripheral vasoconstriction by stimulating the release of 
vasoactive substances such as renin, from the kidney, and vasopressin, from 
the pituitary (Guyton, 1980). At rest the sympathetic nervous system is the 
primary effector of the tone of the cardiovascular system. This tone is 
maintained by a minimal but constant release of neurotransmitters to the 
components of the cardiovascular system, with the sympathetic nervous system 
dominant over the parasympathetic system at rest (Clark et al., 1982). The 
magnitude of the initial response of arterial pressure to changing cardiovascular 
situations is therefore a reflection of the degree of sympathetic stimulation 
which, in turn, is determined and coordinated by regulatory centers in the 
central nervous system. Although there is still no concensus on whether or not 
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measurements of plasma catecholamines provide an index of sympathetic tone 
in the resting state, there does appear to be a positive correlation between 
plasma catecholamine concentrations and sympathetic activity in response to 
work intensity (Guthrie & Kotchen, 1984). 
Parasympathetic stimulation is generally associated with vasodilation and 
decreased heart rate and blood pressure (Clark et al., 1982). Parasympathetic 
preganglionic neurons originate primarily from the dorsal motor nucleus of the 
vagus and the nucleus ambiguus, with projections to the heart extending from 
both areas (Guthrie & Kotchen, 1984). Although there is documented evidence 
that parasympathetic stimulation of the heart results in a decreased heart rate 
there is very litte evidence for active neurogenic vasodilation in the systemic 
vessels of most species (Burnstock & Griffith, 1988). Acetylcholine released 
from parasympathetic neurons has been shown to cause dilation of systemic 
arteries by acting on muscarinic receptors on the endothelium (Burnstock & 
Griffith, 1988). This action causes local release of endothelium derived relaxing 
factor (EDRF) which results in local vasodilation (Furchgott & Zawadzki, 1980). 
The chemical components of EDRF are currently unknown, however, early 
research has ruled out any prostaglandin, adenosine, and adenosine 
monophosphate (AMP) as the possible active factor (Furchgott, 1983). The 
EDRF mechanism is presently the only recognized path for parasympathetic 
innervated vasodilation of the peripheral vasculature. Furchgott (1983) has 
suggested that the relaxation observed with the release of EDRF may be due to 
a combined effect of other non-neural mechanisms acting with the EDRF and 
not solely to the action of EDRF. 
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Hypothalamic Regulation. 
The hypothalamic nuclei involved in cardiovascular regulation receive 
their sensory input primarily from the regulatory centers in the brain stem. 
Stimulation of these nuclei elicit either increases or decreases in heart rate, 
cardiac output, and blood pressure depending on the origin of the signal and 
which branch of the autonomic nervous system is stimulated (Varner, Barman, 
& Gebber, 1988). The lateral and posterior hypothalamic areas, as well as the 
ventrolateral hypothalamic nucleus contain sympathoexcitatory regions. 
Stimulation of these regions results in increased arterial pressure, heart rate, 
and vascular resistance (Wyss et al., 1990). Nuclei in the lateral and posterior 
hypothalamus contain neurons which project directly to the medulla and the 
spinal cord, providing a link between the brain centers and the peripheral 
vascular system. The paraventricular nucleus of the hypothalamus is also tied 
to the medulla and to the autonomic nervous system in the spinal cord. Its 
difference lies in the fact that it also regulates secretion of vasopressin by the 
pituitary and projects to the vagal parasympathetic nuclei as well as the thoracic 
sympathetic neurons (McKeller & Loewy, 1981). 
Research suggests that both vagal and sympathetic outflow are 
controlled by the anterior hypothalamus (McKeller & Loewy, 1981). Blood 
pressure changes observed with stimulation of the anterior region suggest a 
strong role in sympathoinhibitory control of arterial pressure, while activation of 
the posterior hypothalamus increases sympathetic activity leading to increased 
vascular tension (Wyss et al., 1990). 
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Central Nervous Control and Hypertension. 
Subtle alterations in the organization of neural mechanisms involved in 
cardiovascular regulation or in the neurochemistry of the central nervous system 
may result in hypertension. Further, these neural imbalances may manifest at 
the central and/or the peripheral level. The central nervous system regulates 
cardiovascular homeostasis through a widely distributed network of neural 
circuits integrating regulating brain centers with the spinal cord and effector 
organs, such as the heart and vascular tissue. Alterations in the sensory input 
to the brain centers, in the control signals these centers send to the effector 
organs, or in the responsiveness of these organs may result in hypertension. In 
some hypertensives the baroreflex system is reset, requiring an increased 
arterial pressure for stimulation of the appropriate brain centers (Sealy & Laragh, 
1990). Sympathetic nervous activity, a primary pathway in brain center control, 
is altered in nearly all forms of human and experimental hypertension (Goldstein 
& Kopin, 1990; Wyss et at., 1990). The normal response to increased arterial 
pressure is a reduction in sympathetic nervous activity, however, this activity 
may be normal or increased in hypertensives (Wallin, Morlin, & Hjemdahl, 1987). 
Decreasing sympathetic activity by either surgical or chemical means reduces 
arterial pressure in many hypertensives (Wallin et al., 1987). Wyss et al. (1990) 
have suggested that some of the drugs used to lower arterial pressure do so by 
direct action on areas of the central nervous system. 
In addition to observed differences in sensory input and sympathetic 
nervous activity, alterations in cardiac output, organ vascular resistance, and 
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total peripheral resistance have been noted in hypertensive individuals (Frohlich, 
1987). The increased cardiac output observed in young individuals in the early 
stages of hypertension can be explained in part by an observed redistribution of 
the intravascular volume to the central circulation, a faster heart rate, and 
increased myocardial contractility (Frohlich, 1987). Increased peripheral and 
organ vascular resistance may be related to altered vascular membrane ion 
transport or to structural alterations in the vascular tissue (Postnov & Orlov, 
1985). In the majority of adults with mild, moderate or severe hypertension an 
increased peripheral and organ vascular resistance and a normal cardiac output 
are present (Frohlich, 1987). 
The Role of Opioid Peptides 
Opioid peptides are chemical transmitters which perform a role similar to 
that of catecholamines. Numerous opioid peptides and their receptors have 
been found centrally in various brain nuclei involved in cardiovascular control, 
and peripherally in the heart, blood vessels, sympathetic nerves, and adrenal 
gland (Feuerstein & Siren, 1987). These peptides have at least two functionally 
different amino acid sequences; an active site that binds with a specific receptor 
to initiate a specific response, and an auxiliary amino acid sequence which may 
contribute to the affinity of the peptide for a specific receptor and protect it from 
degradation (Burnstock & Griffith, 1988). These peptides can be grouped into 
three main categories, each with its own characteristic precursors, distribution, 
and receptor affinities; beta-endorphin (B-endorphin), enkephalins, and 
dynorphins (Grossman & Sutton, 1985). 
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Opiates from each of the major categories have been found in the central 
nervous system, with both endorphins and enkephalins present in measurable 
levels in the circulation (Grossman & Sutton, 1985). Enkephalins have been 
identified in nerve terminals surrounding the nucleus tractus solitarius, the dorsal 
vagal nucleus, and the nucleus ambiguus, all areas involved in cardiovascular 
regulation (Thoren, Floras, Hoffmann, & Seals, 1990). These opiates in the 
central nervous system are thought to influence cardiovascular function in much 
the same manner as catecholamines, i. e. stimulation via receptor activation 
(Burnstock & Griffith, 1988). Opioid peptides may influence the peripheral 
cardiovascular system via peptidergic innervation of end organs of blood 
pressure control, receptor activation by circulating opiates, or there may be 
local generation of opiates in the peripheral vasculature which moderate its 
activity (Burnstock & Griffith, 1988). 
Several opiate actions in cardiovascular regulation have been 
documented. It has been firmly established that opioid peptides exert an 
inhibitory effect on the release of posterior pituitary hormones such as 
vassopressin (Grossman & Sutton, 1985; McArthur, 1985). Injection of B-
endorphins into the nucleus tractus solitarius region of laboratory animals 
produces vascular hypotension (Guthrie & Kotchen, 1984). Likewise, injection 
of dynorphins into the periventricular hypothalamic nucleus decreases arterial 
pressure (Guthrie & Kotchen, 1984). Peripherally, stimulation of opioid 
receptors located on systemic vessels and other cardiovascular structures 
appears to inhibit peripheral sympathetic transmission (Thoren et al., 1990). In 
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general, research has shown that both central and peripheral administration of 
opiates produces bradycardia and vascular hypotension through inhibition of 
sympathetic outflow and the enhancement of parasympathetic responses 
(Thoren et al., 1990). Caution has been indicated however, in the assumption 
that peripheral circulating levels of opiates is a reflection of central opiate 
activity. Since the blood-brain barrier is relatively impermeable to opioid 
peptides, the relationship between central and peripheral levels of opiates 
remains conjecture until research has established the specific brain site(s) of 
action mediating the effect of opiates on the periphery. 
Role of the Kidneys 
The kidneys affect blood pressure primarily through two mechanisms, 
regulation of blood volume, and the vasoconstrictor action of angiotensin II on 
the smooth muscle vasculature. The ability of the kidneys to affect the long-
term regulation of arterial pressure by controlling the volume of body fluids, 
particularly blood volume, has been known for some time (Guyton, 1980). The 
basic mechanism is as follows: when the arterial pressure rises beyond a 
certain point, the kidneys increase their output of water and electrolytes causing 
a drop in blood volume and a return to normal pressure. One very important 
feature of this mechanism, which distinguishes it from buffering mechanisms like 
those involved in acute and intermediate pressure control, is its potential to 
return arterial pressure to its original value. 
Cardiac output is directly influenced by the kidney's control of blood 
volume. This can be explained by a more in-depth discussion of the regulating 
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mechanism. The steps are as follows: 
1. Increases in the arterial pressure result in an increased volume output 
from the kidney (i.e. increased urinary output). 
2. The decrease in extracellular fluid volume results in a decreased blood 
volume. 
3. This decrease in blood volume leads to a decrease in the mean 
circulatory filling pressure (a measure of the compactness of the blood in 
the circulation). 
4. This decrease leads to a decrease in the venous return to the heart 
which causes a decrease in the cardiac output and thus, a decrease in 
the arterial pressure. 
As stated earlier, this mechanism has the potential to return arterial 
pressure to normal values, this has been demonstrated in dogs into which a 30 
percent increase in blood volume was induced by blood transfusion (Dobbs, 
Prather, & Guyton, 1971). The unique factor in this study however, was that the 
dogs had their nervous system destroyed so they were devoid of nervous 
reflexes, leaving the kidneys as the major regulator of arterial pressure. When 
cardiac output and blood volume values have been measured in hypertensive 
individuals, lower than normal blood volumes (Ulrych, 1973) and either normal 
or below normal cardiac output (Frohlich, 1987) have been observed. These 
observations are contradictory to what would be expected if the regulation of 
blood volume were the primary factor in essential hypertension. These results 
also lend strength to the hypothesis that hypertension is primarily a disfunction 
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in peripheral resistance since a higher vascular tension must be present to 
counter the lower cardiac output and produce the observed hypertension. 
In addition to affecting arterial pressure through blood volume regulation, 
the kidneys also, affect pressure by acting on peripheral resistance through the 
renin-angiotensin-aldosterone system. Renin is a proteolytic enzyme formed in 
the juxtaglomerular cells located primarily in the walls of the afferent arterioles of 
the kidneys. When there is a decrease in arterial pressure, which can result 
from sodium depletion, dehydration, or sympathetic stimulation, the 
baroreceptors in the kidney's afferent arterioles are stimulated, and renin is 
formed and released into the blood. Renin acts on renin substrate 
(angiotensinogen), formed in the liver, to form angiotensin I, which is acted on 
by converting enzyme in the lungs and kidneys to form angiotensin II. 
Angiotensin II exerts a powerful, direct, and immediate vasoconstrictive effect on 
the arterial bed by increasing the cytosolic ionized calcium levels of the smooth 
muscle cells. It also acts on the adrenal cortex to increase secretion of 
aldosterone which, in turn, acts on the renal tubules to increase reabsorption of 
sodium and water. 
Renin, unlike other plasma enzymes, has no inhibitor, only its secretion is 
regulated. Therefore, once renin is in the blood it can continuously produce 
angiotensin I as long as the liver provides sufficient amounts of substrate. 
Research has indicated that amounts of angiotensinogen produced by the liver 
and angiotensin converting enzyme produced in the lungs are not rate limiting in 
the production of angiotensin II (Sealey & Laragh, 1990). Negative feedback 
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from the levels of angiotensin II, vasopressin, and atrial natriuretic factor is the 
only limitation on the rate of renin secretion. 
Renin release is stimulated by the action of epinephrine on the Beta-1 
(BJ receptors on the juxtaglomerular cell membrane, and by the circulating 
levels of prostaglandin l2, prostaglandin E2, kallikrein, and other kinins. Available 
evidence suggests that all of the factors which stimulate renin release do so by 
changing the intracellular concentration of ionized calcium in the juxtaglomerular 
cells, with an increase in concentration suppressing release and a decrease 
stimulating it (Sealey & Laragh, 1990). 
Since renin is primarily secreted when blood volume is reduced, the low 
blood volumes observed in some hypertensives (Ulrych, 1973) may be 
countered to some extent by the high renin profiles observed in certain groups 
of hypertensives (Weber & Drayer, 1984). Marked elevation in plasma renin 
concentration has also been observed in normal individuals after 20 minutes of 
continuous exercise (Goldstein & Kopin, 1990). At one time it was proposed 
that individuals with high renin profiles had a "vasoconstricted" form of 
hypertension while those with low profiles had a more volume-dependent form 
(Frohlich, 1987). Although there is little evidence to justify classification based 
solely on renin profiles, differences in these profiles have been incorporated into 
a broader and more widely accepted classification proposal. Stoy (1988) has 
proposed two classifications: The Type I defect is characterized by low serum 
ionized calcium levels, increased 1, 25 dihydroxycholecalciferol levels, and 
decreased plasma renin activity compared to that of normotensives; the Type II 
25 
defect, on the other hand, is characterized by increased serum ionized calcium, 
decreased 1, 25 dihydroxycholecalciferol, and increased plasma renin activity. 
Since renin secretion is positively associated with vasoconstriction and low 
levels of renin activity are observed in some forms of hypertension, it may be 
assumed that while alterations in renin secretion are a factor in the increased 
vascular tension observed in some hypertensives, they are not the sole factor. 
The Role of Calcium in Vascular Tension 
It has been suggested that hypertension is a disorder of cell function and 
that this dysfunction resides in the cells of one or more of the tissues primarily 
involved in pressure regulation: neural synapses, adrenal glomerulosa, 
juxtaglomerular apparatus, or the vascular smooth muscle cells (Rasmussen, 
1983). Since the major means by which the secretion of norepinephrine, renin, 
and aldosterone are regulated, and by which norepinephrine and angiotensin II 
affect the contractile state of the vasculature is by altering the vasculature or the 
cellular organelles to allow either an increased influx of ionized calcium into the 
cell or a decreased efflux from the ceil, the proposed cellular dysfunction in 
hypertension possibly involves a disorder of cellular calcium metabolism. 
Force generation in the vascular smooth muscle is produced in a manner 
similar, but not identical, to the sliding filament model present in skeletal 
muscles (Bohr & Webb, 1984). In both types of muscle, force is developed as a 
result of the formation of myosin cross-bridges alternately attaching and 
detaching from the actin molecule sliding one filament over the other. This 
cycling, in both muscle types, is initiated by an increase in the intracellular 
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concentration of ionized calcium (Bohr & Webb, 1984). The main difference 
between the two muscle types is in the control of the cycling process. In 
skeletal and cardiac muscle, the process is controlled by a troponin-based 
system present on the actin filament. Smooth muscle contractility, on the other 
hand, is regulated by the myosin light chain, which is a component of the head 
of the myosin molecule. It has been fairly well established that in smooth 
muscle, tension production is a function of the rate of cross-bridge cycling, 
which in turn is determined by the degree of phosphorylation of the myosin light 
chain (Bohr & Webb, 1984; Rasmussen, 1983). The degree of myosin light 
chain phosphorylation is directly proportional to the cytosolic concentration of 
ionized calcium, making cellular calcium metabolism an important component of 
vascular tension. If hypertension does involve a dysfunction of cellular calcium 
metabolism, it may manifest itself in the mechanisms which regulate the 
cytosolic concentration of ionized calcium or the phosphorylation of myosin light 
chain. 
Regulation of Extracellular Calcium Concentration. 
Entry of ionized calcium from the extracellular space into the cytosol of 
the vascular smooth muscle cell initiates vascular contraction (Khalil, Lodge, 
Saida, Gelband, & van Breeman, 1990). The regulation of extracellular calcium 
concentration is dependent upon the net effect of intestinal absorption, skeletal 
accretion and resorption, renal filtration and resorption, and the degree of 
calcium binding to anionic sites in the extracellular medium (McCarron, 1985). 
These processes are in turn affected by systemic pH, temperature, and the 
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concentrations of serum protein, parathyroid hormone, calcitonin, and vitamin D 
in the circulation. The end result is a total calcium concentration in the 
extracellular fluid, fairly rigidly maintained in the range of 2-5 millimolar (mM). 
The actions of vitamin D in regard to calcium concentration include: a) intestinal 
absorption of calcium, b) the mobilization of calcium from bone, and c) renal 
reabsorption of filtered calcium. Parathyroid hormone, secreted when the 
plasma ionized calcium concentration falls below the parathyroid setpoint of 
approximately 4.5 mg/100 ml (approximately 1.12 mM), also acts to stimulate 
the mobilization of calcium from bone and renal reabsorption of calcium. Along 
with these functions parathyroid hormone also stimulates the conversion of 25-
hydroxycholecalciferol to 1, 25-dihydroxycholecalciferol in the kidney, which is 
the form of vitamin D necessary for the intestinal absorption of calcium. Also 
stimulated by the level of plasma calcium is the secretion of calcitonin from the 
thyroid gland. While parathyroid hormone is secreted in response to low levels 
of plasma calcium, calcitonin is released in response to rising levels, due either 
to an increase in intestinal absorption of calcium or increased calcium resorption 
from bone. Calcitonin acts to inhibit calcium resorption from bone, thereby 
reducing its plasma concentration toward normal. It is primarily the actions of 
parathyroid hormone, calcitonin, and vitamin D which maintain the extracellular 
ionized calcium levels within the narrow 2-5 mM range. 
The total concentration of extracellular calcium can be divided into three 
main fractions, a protein bound fraction, a complexed fraction, and an ionized 
fraction. Generally, the protein bound and the complexed fractions are in 
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equilibrium with the ionized fraction comprising approximately 40,10 and 50 
percent of the total calcium concentration, respectively (Robertson, 1988). 
Although there is likely to be a role for the complexed or protein bound 
fractions, no physiologically important role has presently been identified. The 
ionized fraction is generally regarded as the factor of primary physiological 
importance in extracellular calcium homeostasis. The ionized calcium fraction is 
maintained under strict hormonal control with the mean normal plasma ionized 
calcium concentration at 4.7 mg/100 ml (Robertson, 1988). The plasma ionized 
calcium concentration changes very little over the life span with an intra-
individual variation of normally not more than 0.1 mg/100 ml, which is close to 
the detection limits of most analytical techniques. Further, no significant sex 
difference in plasma ionized concentrations has been observed (Robertson, 
1988). 
Total calcium is often used as an index of calcium homeostasis since a 
correlation between total and ionized calcium in plasma has been suggested 
when the full range of plasma calcium values are computed (Marshall, 1976). 
This measure, however, is not completely valid if the plasma protein 
concentrations or plasma pH are abnormal since the concentration of albumin-
bound calcium may vary with blood pressure (Fogh-Andersen, Hedegaard, 
Thode, & Siggaard-Andersen, 1984). Although some studies have reported no 
differences in total or ionized calcium concentrations between groups of 
hypertensives and sex- and age-matched normotensives (Strazzullo et al., 
1983), others have reported significant correlations between total calcium and 
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blood pressure (Kesteloot & Geboers, 1982) and ionized calcium and blood 
pressure (Fogh-Andersen, et al., 1984). Although these studies reported the 
total or ionized plasma calcium concentrations, no information on the 
contributions of the protein bound or complexed fractions were mentioned. 
Pottgen and Davis (1977) reported a significant inverse relationship (r = -0.99), 
based on linear regression, between plasma ionized calcium and plasma 
albumin regardless of whether the ionized calcium was measured directly or 
calculated. Since albumin-bound calcium is a component of the protein bound 
calcium fraction, it is possible that alterations in the concentration of the protein 
bound fraction may affect the concentration of the ionized calcium fraction. In 
contrast to the inverse relationship reported by Pottgen and Davis (1977), two 
independent studies, utilizing different methods of collecting and storing 
samples and different apparatus for measuring ionized calcium concentrations 
and pH, reported significant positive correlations (p<0.001) for ionized calcium, 
adjusted for pH, with albumin concentration (Butler, Payne, Gunn, Burns, & 
Paterson, 1984). The authors concluded that there was a definite association of 
low plasma ionized calcium concentrations and low plasma albumin 
concentrations in individuals with hypoalbuminemia. Butler et al. (1984) further 
indicated that this positive association may have been due to a high prevalence 
of malnutrition in their subjects or, more likely, to a positive interference by 
plasma proteins with the calcium measuring instruments. Identification of a 
relationship between serum albumin and serum ionized calcium concentrations 
has led to the development of several formulas, utilizing a mean value of 40 or 
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42 grams/liter (g/L) for serum albumin (Butler, et alM 1984; Hvarfner, 
Bergstrom, Morlin, Wide, & Ljunghall, 1987). These formulae adjust the total 
calcium concentration so that a clearer picture of the relationship between 
serum ionized calcium and serum total calcium can be viewed without serum 
albumin as a confounding variable. Although these studies have indicated both 
positive and negative correlations between serum ionized calcium and serum 
albumin concentrations, and that alterations in the serum ionized calcium 
concentration are possible without being reflected in the total calcium values, no 
measurement of blood pressure was reported. Further, no measurements or 
estimates of the protein-bound or complexed calcium fractions and their 
relationship to the total calcium concentration were made in these studies. 
When the relationship between blood pressure and calcium indices has 
been examined, no significant relationships between any blood pressure 
variable and total serum calcium or albumin modified total serum calcium were 
reported (Hvarfner et al., 1987). However, Hvarfner et al. (1987) did report a 
significant inverse relationship (p<0.0001) between plasma ionized calcium and 
blood pressure, a significant positive relationship between serum albumin 
concentration and mean arterial (p=0.001), diastolic (p=0.002), and systolic 
pressures (p=0.005), and indicated that there was an inverse association 
between serum ionized calcium and serum albumin. 
Regulation of Intracellular Calcium Concentration. 
While the extracellular ionized calcium concentration is in the millimolar 
range, its intracellular concentration is generally 100-100,000 times lower. 
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Because of this vast gradient, activation of such calcium-regulated processes as 
secretion and contraction only require changes in the micromolar (uM) range. 
The rate of movement of calcium ions across the plasma membrane is primarily 
controlled by the relative impermeability of the membrane to calcium and by the 
action of various calcium channels in the membrane. The plasma membrane 
may be viewed as a two-dimensional mosaic consisting of integral proteins 
embedded in a lipid layer with other proteins loosely bound to both the inner 
and outer surfaces. Calcium ions from the extracellular medium bind to the 
protein fraction of the membrane causing an increase in protein cross-linking in 
the lipid layer. This binding by calcium increases the rigidity of the membrane 
which increases its electrical resistance (Tobias, Agin, & Pawlowski, 1962). In 
addition, this calcium binding acts to increase membrane surface pressure by 
condensing the lipid bilayer, decrease the thickness of the bilayer, and reduce 
the fluidity of the membrane by stabilizing the phospholipid moiety (Robertson, 
1988). The stabilization of the phospholipid moiety is achieved through the 
formation of a calcium-ATP-phospholipid complex. The combined effect of 
calcium ions on both the phospholipid and protein moieties in the membrane is 
the creation of "channels" which define the membrane's permeability to various 
ions (Robertson, 1988). 
Vascular smooth muscle cell membranes contain a number of different 
receptor sites and are electrically connected to one another via nexuses, 
allowing changes in membrane permeability to be brought about by either 
agonist application or membrane depolarization. A strong correlation between 
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influx of extracellular ionized calcium across the plasma membrane and the 
state of vascular contraction has been suggested by studies utilizing calcium 
antagonists and agonists. Calcium ion antagonist blockage of calcium-45 (4SCa) 
influx was observed to be associated with inhibition of vascular force 
development (van Breemen, Mangel, Fahim, & Meisheri, 1982), while 
augmented ion influx by the agonist Bay K8644 was observed to enhance force 
development (Yamamoto, Hwang, & van Breemen, 1984). The combination of 
these observations and an understanding of calcium's effects on the plasma 
membrane have led to the postulation of three major pathways of calcium entry 
into the cell. The first, or voltage-gated channel, has been identified in a variety 
of different tissues (Rassmussen, 1983) and allows increased calcium ion entry 
upon membrane depolarization. The second, or receptor-operated channel, 
allows increased ion influx upon stimulation of specific membrane receptors 
such as stimulation of alpha-receptors by angiotensin II. The third pathway has 
been referred to as the leak pathway (Khalil, Lodge, Saida, Gelband, & van 
Breeman, 1990). In this pathway calcium ions cross the resting plasma 
membrane in the absence of membrane stimulation by depolarization or 
receptor activation. The magnitude of this calcium leak, as determined by 45Ca 
flux measurements in resting rabbit aorta, is approximately 15 umol/kg/min 
(Khalil et al., 1990). It has been suggested that this leak of calcium ions across 
the membrane occurs via the sodium-channel (Rasmussen, 1983), and that it is 
continually compensated for by sequestration into the endoplasmic reticulum 
and by calcium ion extrusion to the extracellular space (Khalil et al., 1990). 
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While it has been concluded that sufficient physiologic and biochemical 
evidence exists to support the presence of sodium-calcium ion exchange 
(Young, Bukoski, & McCarron, 1990), the extent of its contribution to 
intracellular calcium regulation is currently unknown. Thus, this pathway may 
play a greater role in vascular smooth muscle activation if cellular mechanisms 
responsible for sequestration or expulsion are compromised in any way. 
In addition to the three primary pathways of calcium ion influx, it has 
been suggested that stretch or elevated intravascular pressure can result in a 
maintained increase in vascular smooth muscle tone (Khalil et al., 1990). 
Further, evidence indicates that this fourth pathway or stretch-activated channel, 
is highly influenced by extracellular calcium ion concentration (Bohr & Webb, 
1984). Evidence in support of the existence of this fourth pathway comes from 
observations that stretching of the smooth muscle vasculature stimulates Ca4S 
influx (Laher, Hwa, & van Breeman, 1988) and that it can also open nonspecific 
cation channels in the smooth muscle membrane (Kirber, Singer, & Walsh, 
1987). 
Maintenance of calcium ion homeostasis in the cytosol is vital for the 
prevention of cell intoxication and regulation of the biological systems 
dependent on changes in the intracellular calcium ion concentration. Cytosolic 
calcium ion concentration is primarily regulated by the actions of an energy-
dependent calcium-magnesium-ATPase (Ca-Mg-ATPase) pump, which actively 
moves calcium ions back across the plasma membrane, and a calcium-sodium 
ion exchange system which exchanges intracellular calcium ions for extracellular 
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sodium ions (Postnov & Orlov, 1985; Rasmussen, 1983). Both systems are 
located in the plasma membrane and extrude calcium ions from the cell against 
a concentration gradient. In addition to these two systems, the cell can also 
regulate calcium ion concentration through its binding in the cytosol to various 
substrates, such as citrate, phosphate, troponins, and calmodulin; sequestering 
of the ions into subcellular compartments, such as the endoplasmic reticulum, 
microsomes, and the mitochondria; and through the stabilizing effect of calcium 
ions on the permeability of the plasma membrane (Campbell, 1988). The overall 
effect of these internal systems is to maintain up to 98 percent of the total 
intracellular calcium concentration either localized in intracellular compartments 
or bound to membrane structures and cytoplasmic substrates. Since only 
micromolar changes in ionized calcium concentration are necessary to induce 
stimulation, shifts in the functioning of these internal regulating systems could 
lead to alterations in its intracellular concentration, affecting calcium-dependent 
mechanisms. Systems involved in vascular contraction, neurotransmitter 
release, and membrane ionic permeability, all factors in vascular tension, are all 
calcium-dependent mechanisms. Therefore,an association between micromolar 
alterations in ionic calcium levels and the level of vascular tension has a definite 
theoretical basis. 
In principle, an increase in the intracellular calcium ion concentration 
could result from an increased release from internal stores, an increased 
permeability of the plasma membrane, an inhibition of the mechanisms 
responsible for calcium efflux, or a decrease in the ability of subcellular 
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components to bind or sequester calcium. A small increase in plasma 
membrane permeability or a small fractional release of calcium ions from a 
subcellular component will lead to a large fractional rise in cytosolic ionized 
calcium levels to a level several fold greater than that of the cell in its non-
activated state. In studies on smooth muscle, nerve terminals, endocrine cells, 
and platelets, where external ionized calcium has been removed, intracellular 
stores have been depleted or inhibited from releasing calcium, and it has been 
demonstrated that the bulk of the increase in intracellular ionized calcium 
necessary for cell activation comes from an internal store, probably a portion of 
the endoplasmic reticulum (Campbell, 1988). 
Mechanisms of Intracellular Calcium Activation. 
The association of a calcium-mobilizing agonist with its receptor or 
depolarization of the plasma membrane, results in an influx of calcium ions from 
the extracellular medium into the plasma membrane. As calcium ions enter the 
membrane's lipid bilayer through their respective channels, activation of the 
phosphodiesterase, phospholipase C, occurs. Phospholipase C preferentially 
hydrolyses the membrane phospholipid phosphatidylinositol 4,5-bisphosphate 
(PIP2), into 1,2-diacylglycerol (DG) and inositol 1,4,5-trisphosphate (IP3) (Khalil, 
et al., 1990). Diacylglycerol is a lipid-soluble compound which acts with 
phosphatidylserine and the calcium ions entering the membrane to change the 
conformation of protein kinase C (PKC), exposing its active catalytic site and 
thus increasing its binding affinity for calcium and its ability to activate other 
biological systems (Campbell, 1988). The cellular responses elicited by PKC 
36 
activation are separate from and synergistic to those activated via an increase in 
intracellular ionized calcium and include increased catecholamine release from 
the adrenal medulla and neuronal synapses, increased muscular contraction, 
and increased parathyroid hormone release (Nishizuka, 1989), all of which can 
alter vascular tension. Additionally, PKC appears to be involved in the 
phosphorylation of key actin-binding proteins which may play a role in the 
regulation of vascular contractile mechanisms (Young et al., 1990). 
Inositol trisphosphate is a water-soluble compound which moves from the 
membrane into the cytosol where it has been shown to be responsible for the 
release of ionized calcium from internal stores, most likely from a compartment 
of the endoplasmic reticulum (Streb, Irvine, Berridge, & Schulz, 1983; Suematsu, 
Hirata, Hashimoto, & Kuriyama, 1984). The mechanism by which IP3 promotes 
the release of ionized calcium from internal stores, however, is not presently 
known. This release of calcium by IP3 activates the second major calcium 
messenger pathway, distinct from the PKC pathway activated by DG. This 
pathway involves the binding of the excess calcium ions to calmodulin or 
troponin C. The binding of calcium ions to these proteins causes a 
conformational change in their structure, increasing their affinity for calcium ions 
and allowing them to complex with other proteins or response elements and 
initiate various biological events such as muscle contraction and increased 
activity of ionized calcium efflux mechanisms. The increase in intracellular 
calcium ion levels acts synergistically with IP3 increasing the rate of release from 
the endoplasmic reticulum (Khalil et al., 1990). This synergistic action of 
37 
increased calcium levels has been called calcium-induced calcium release and it 
has also been suggested to induce the release of calcium ions bound to the 
inner plasma membrane (Rasmussen, 1983). 
The increase in intracellular ionized calcium in vascular smooth muscle 
from 10~7 moles/liter (mol/L) to 10~6 mol/L is the primary initiator of vascular 
contraction. The formation of a calcium-calmodulin-response element complex 
results in activation of the calcium-dependent protein kinase, myosin light chain 
kinase (MLCK), stimulating the phosphorylation of myosin light chain (MLC), 
which in turn activates the myosin head of protein filament resulting in sliding of 
the filaments and contraction. Research has indicated that the state of tonic 
contraction in vascular smooth muscle is positively correlated with the degree of 
phosphorylation of MLC (Rasmussen, 1983). 
Calcium Metabolism and Vascular Relaxation. 
While activation of alpha-1 receptors on the plasma membrane or 
membrane depolarization results in increases in vascular tension, catecholamine 
activation of beta-2 (B2) receptors on the cell surface result in smooth muscle 
relaxation (Rasmussen, 1983). The activation of Bz receptors by 
catecholamines leads to a rise in cyclic adenosine monophosphate (cAMP) 
concentration which increases protein kinase activity. This increased activity 
results in protein phosphorylation at three major sites: the plasma membrane, 
the endoplasmic reticulum, and the cytosol (Rasmussen, 1983). Protein 
phosphorylation at the plasma membrane results in activation of the 
sodium/potassium ATPase (Na+/K+ ATPase) pump, which upon activation, 
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lowers the intracellular sodium ion content by actively extruding sodium ions into 
the extracellular medium, against the concentration gradient. This lowering of 
the intracellular sodium concentration stimulates the exchange of extracellular 
sodium ions for intracellular calcium ions through sodium channels in the 
membrane (Rasmussen, 1983). Thus, intracellular sodium ion concentration 
returns to normal at the expense of the cytosolic calcium ion concentration. 
Phosphorylation at the endoplasmic reticulum membrane leads to increased 
activity of the calcium-ATPase (Ca2+-ATPase) pump resulting in increased 
transport of cytosolic calcium ions into the endoplasmic reticulum. The overall 
effect of phosphorylation at both of these membrane sites is calcium ion efflux 
from the cytosol, resulting in a lowered ionized calcium level, and ultimately a 
decrease in vascular tension. The third site of phosphorylation is the protein 
kinase MLCK in the cytosol. Phosphorylation of MLCK decreases its sensitivity 
to activation by calcium, and since the degree of vascular tension is proportional 
to the degree of phosphorylation of MLC (Rasmussen, 1983), a lower 
concentration of phosphorylated MLC leads to a lower level of vascular tension. 
Calcium Metabolism and Hypertension 
The metabolic pathways by which disturbed calcium homeostasis 
produces a rise in arterial pressure remain conjectural. Available data suggest 
that factors which reduce the vascular plasma membrane's exposure to ionic 
calcium or impair intracellular storage or efflux of calcium ions may lead to 
increased vascular tension (McCarron, 1985). The presence of these alterations 
leads to a less stable vascular plasma membrane, increased membrane 
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permeability to calcium, and a greater influx than efflux of calcium ions. An 
alteration in the binding kinetics of extracellular bound calcium, making it less 
available for mobilization, is one possible mechanism whereby an alteration in 
calcium metabolism could lead to vascular smooth muscle dysfunction. Such 
an abnormality is a possible explanation for the normal serum total calcium and 
decreased extracellular ionized calcium levels observed in both humans and 
experimental animals with high blood pressure (McCarron, 1985). A defect in 
the transport of calcium across the plasma membrane is another possible 
mechanism which might alter the intracellular and extracellular calcium levels, 
thereby adversely affecting vascular smooth muscle function. 
Since it is difficult to study human smooth muscle cell function, various 
models such as the erythrocyte, lymphocyte, and blood platelet have been 
used. Although no direct relationship between these blood cell models and 
smooth muscle cells, with regard to calcium metabolism, has been established, 
there is evidence of calcium mechanisms present in all. Platelets, like smooth 
muscle cells, have an alpha-2-adrenoceptor-adenylate cyclase system and a 
calcium-dependent contraction-coupling mechanism (Erne et al., 1984; 
Rassmussen, 1983). Additionally, the majority of platelet intracellular calcium is 
associated with cellular mitochondria, storage granules, the plasma membrane, 
and the dense tubular system, which in platelets is analogous to the 
endoplasmic reticulum of muscle (Salzman & Ware, 1988). Generation of IP3, in 
a manner similar to that in the sarcolemma, acts on the dense tubular system in 
the platelet to raise the cytosolic calcium level. This intracellular rise in free 
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calcium may reach two to three micromolar, as indicated by the fluorescent dye 
indicators fura-2 or indo-1 (Salzman & Ware, 1988). This process in the platelet 
mirrors that in the vascular smooth muscle cell, resulting in phosphorylation of 
MLC, activation of calmodulin, and stimulation of the processes which result in 
increased vascular tension. Higher intracellular ionized calcium levels in 
platelets have been reported in patients with hypertension and also found to be 
directly associated with blood pressure (Erne et al., 1984). Erne et al. (1984) 
suggested that their results may be due to a defect in membrane permeability or 
to possible alterations in the calcium membrane pump mechanism. 
In both human hypertension and hypertension in experimental animals, 
disorders in calcium metabolism have been reported in a variety of organ 
functions, biochemical parameters, and subcellular organelles (McCarron, 1982; 
McCarron, 1985). In the laboratory, vascular tissue from hypertensive animals 
has been reported to exhibit increased membrane permeability, altered binding 
kinetics on the cell membranes, and accumulation of calcium in subcellular 
fractions (McCarron, 1982; McCarron, 1985; Webb & Bohr, 1978). The 
biochemical disorders associated with calcium metabolism in human and 
experimental hypertension are varied. Several studies have compared serum 
and intracellular calcium fractions in hypertensive and normotensive subjects 
(Bing, Heagerty, Jackson, Thurston, & Swales, 1986; Erne et al., 1984; Folsom 
et al., 1986; Le Quan Sang & Devynck, 1986; McCarron, 1982). Folsom et al. 
(1986) found significantly lower mean levels of serum ultrafilterable calcium 
(p=0.01), a combination of the ionized and complexed calcium fractions, and 
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serum complexed calcium (p=0.04), with a trend toward lower levels of serum 
ionized calcium (p=0.09) in their comparison of 28 hypertensives to 28 
normotensive controls. Significantly higher platelet ionized calcium levels have 
been found in hypertensives (p<0.001) versus normotensive controls (Erne et 
al., 1984; Le Quan Sang & Devynck, 1986), and a close positive correlation 
between the intracellular free calcium level and both systolic and diastolic 
pressures (r=0.883 and r=0.931 respectively) (Erne et al., 1984). In a study of 
normotensives with (n=17) and without (n=22) a family history of hypertension, 
and of untreated hypertensives (n=22), there was a significant correlation 
between leukocyte intracellular ionized calcium and mean supine blood pressure 
in normotensives with no history of hypertension (r=0.73, p^.0.01) (Bing et al., 
1986). Although serum total calcium has been reported to be normal in some 
studies, free or ionized calcium was decreased (McCarron, 1982; McCarron, 
1985). Other alterations observed in hypertensives include elevated parathyroid 
hormone levels, low serum phosphorus concentrations, abnormal vitamin D 
precursor levels, and both increased and decreased intestinal calcium transport 
(McCarron, 1982; McCarron, 1985). 
The most commonly studied animal model of genetic hypertension is the 
spontaneously hypertensive rat (SHR). Although it is not a perfect model, the 
alterations in calcium metabolism found in the SHR appear to closely 
approximate those in human hypertension (Young et al., 1990). It has generally 
been found that genetic models of hypertension are characterized by an 
increased total peripheral resistance with normal cardiac output, and increased 
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arterial pressor responses to the presence of contractile agents and 
psychological stress, when compared to normotensive counterparts (Young et 
al., 1990). The cellular defects in calcium metabolism observed in the smooth 
muscle cells of the SHR are characterized by an increased permeability of the 
cell membrane to calcium, an increased membrane calcium content, an 
increased mitochondrial calcium content with delayed mitochondrial uptake of 
cytosolic calcium, and altered calcium-sodium countertransport across the 
plasma membrane (McCarron, 1985). 
Dietary Calcium and Blood Pressure 
The functional importance of disordered calcium homeostasis in the 
pathogenesis of high blood pressure has been suggested by several 
epidemiological studies. In humans, decreased dietary (Kesteloot & Geboers, 
1982; McCarron, Morris & Cole, 1982) and environmental exposure (Ackley, 
Barrett-Conner, & Suarez, 1983; Stitt, Crawford, Clayton, & Morris, 1973) to 
calcium has been associated with an increased risk of hypertension. The 
HANES I data, when controlled for age, race, sex, and weight, also indicates 
that calcium consumption is lower in individuals with essential hypertension 
(McCarron, 1985). The assumption drawn from this literature is that reduced 
intake of calcium from either food or water sources is associated with an 
increased probability of hypertension, and ultimately, cardiovascular disease. 
Studies in the SHR and its genetic, normotensive control, the Wistar-
Kyoto rat (WKR), have provided additional evidence that maintenance of calcium 
homeostasis is a factor in blood pressure control (Ayachi, 1979; McCarron, 
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Yung, Ugoretz, & Krutzik, 1981). Both Ayachi (1979) and McCarron et al. 
(1981) reported that supplementation of the SHR's diet with calcium results in a 
marked attenuation of hypertension (p<0.05 and p<.0.0001, respectively) and 
that this effect can be observed in as short a period as two weeks. In contrast 
to diet supplementation, removal or reduction of dietary calcium in the SHR 
results in an acceleration of the animal's development of hypertension. 
Observations in the WKR are consistent with those in the SHR. Blood 
pressure of this normotensive rat also demonstrates an inverse relationship with 
the calcium content of its diet. Increased calcium in the diet results in lower 
pressure in the adult animal, whereas calcium restriction produces borderline 
hypertension (McCarron, 1985). Also, as in the SHR, dietary calcium 
manipulation of as short a duration as two weeks will modify the adult WKR's 
arterial pressure (McCarron, 1985). 
Supplementation studies in human subjects have yielded varied, and 
sometimes conflicting results with regard to blood pressure. Johnson, Smith, 
and Freudenheim (1985) supplemented 34 hypertensive females with one and a 
half grams/day of calcium (as calcium carbonate) for a period of three years. 
Their results indicated significant reductions in systolic blood pressure (mean 
reduction = 13 mm Hg). Another study of 48 hypertensive men and women 
(McCarron & Morris, 1985) reported significant reductions in both systolic and 
diastolic pressures (mean reductions = 5.6 and 2.3 mm Hg for systolic and 
diastolic respectively) after eight weeks of supplementation with one gm/day of 
calcium as the carbonate. Although calcium supplementation studies utilizing 
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hypertensive populations have been consistent in demonstrating reductions in 
blood pressure (Johnson et al., 1985; McCarron & Morris, 1985), those using 
normotensive groups have yielded conflicting results. In one such study of 18-
35 year old women (Belizan et al., 1983) a significant decrease in diastolic blood 
pressure (2.85%, 4.19%, and 5.64% in the seated, lateral, and dorsal positions, 
respectively) was observed following nine weeks of supplementation with one 
gram/day of elemental calcium. Other investigators however, have failed to 
observe significant decreases in either systolic or diastolic pressures in 
normotensive women supplemented with 1.5 gram of calcium per day for a 
three year period (Johnson et al., 1985) or significant correlations between 
dietary calcium and blood pressure (Schramm, Cauley, Sandler, & Slemenda, 
1986). A major difference between the study by Belizan et al. (1983) and those 
failing to show significant results is a difference in the mean age of the groups. 
Belizan et al. (1983) utilized young women age 18-35 (mean = 24.0) while both 
Johnson et al. (1985) and Schramm et al. (1986) used subjects who were 
middle aged or older (age 35-65, mean = 52.0 and age 46-66, mean = 57.0, 
respectively). In genetically hypertensive animals both blood pressure and 
calcium handling have been demonstrated to be dependent on age (Young et 
al., 1990). Thus, hormonal differences, alterations in intestinal calcium 
absorption, or altered cellular calcium handling as a result of age may possibly 
explain the conflicting results observed in these studies. 
The precise mechanism by which dietary calcium intake exerts its 
antihypertensive effect is not known beyond the finding that supplemental 
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calcium results in increased serum ionized calcium levels and does not 
exacerbate calcium loss in the urine (Karanja & McCarron, 1986). It has been 
postulated that dietary calcium intake may lower blood pressure by acting to 
stabilize the vascular smooth muscle cell membrane (Karanja & McCarron, 
1986; Robertson, 1988). 
A major criticism of human calcium supplementation studies is that the 
levels of calcium used are usually in excess of what is observed in normal 
dietary intakes (Karanja & McCarron, 1986). Although significant evidence 
exists that an inverse relationship exists between calcium intake and blood 
pressure (Kesteloot & Geboers, 1982; McCarron, Morris, & Cole, 1982), it is 
currently unknown at what level of calcium intake this effect becomes significant, 
since the literature does not contain studies observing the effects of controlled 
calcium intake on blood pressure. 
Calcium and Pharmacological Treatment of Hypertension 
Since alteration of the free intracellular calcium concentration is the 
ultimate effect of most peripheral vasoconstrictor mechanisms (Kiowski et al., 
1989), reductions in this concentration should result in relaxation of the vascular 
smooth muscle and a concomitant decrease in blood pressure. 
Pharmacological antihypertensive therapy comprises several classes of drugs 
which act directly or indirectly to modify the intracellular calcium concentration in 
vascular tissue. Adrenergic receptor blockers belong to a class of drugs which 
reduce blood pressure by competitively inhibiting the effects of agonists like 
catecholamines on central and peripheral adrenergic receptors. Two types of 
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beta-adrenergic and two types of alpha-adrenergic receptors have been 
identified. Stimulation of beta-1 (BJ receptors increases heart rate and heart 
contractility, resulting in increased blood pressure primarily through increased 
cardiac output (Somani, 1982). Beta-2 (B2) stimulation in the periphery results 
in relaxation of the smooth muscle vasculature and decreased peripheral 
resistance (Somani, 1982). Alpha-1 (Ax) receptor stimulation in smooth muscle 
vasculature is the opposite of Bz stimulation, resulting in vasoconstriction with a 
concomitant rise in blood pressure, while central A2 receptor stimulation inhibits 
presynaptic release of norepinephrine and renin release (Somani, 1982). The 
precise mechanism by which beta-blocking drugs exert their antihypertensive 
effects is presently unknown. It has been hypothesized that they regulate blood 
pressure by inhibiting central mechanisms responsible for regulation of 
circulation (Meier, Orwin, Rogg, & Brunner, 1980), or by reduction of cardiac 
output, lowering of plasma renin concentrations, or reduction of peripheral 
sympathetic activity (Meier et al., 1980; Cohn, 1982; Struthers & Dollery, 1985). 
Since angiotensin II and norepinephrine are potent vasoconstrictors, reductions 
in the concentrations of these agonists would mean that the ultimate beta-
blocking effect at the cellular level is a reduction in the stimulation of receptor-
operated calcium channels and a reduced influx of calcium ions. 
Beta-blocking drugs and alpha-antagonists have the ability to exert their 
effects on both the central nervous system and the periphery (Reid, 1986; van 
Zwieten, 1986). Drugs affecting alpha receptors are thought to act centrally on 
the brain stem to reduce sympathetic outflow, reducing the secretion of 
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catecholamines from sympathetic nerves (Reid, 1986). Peripherally, alpha-
antagonists bind the Ax receptors on the vascular smooth muscle, reducing 
vasoconstriction through limited stimulation of receptor-operated channels and 
reducing calcium influx (Reid, 1986). 
Adrenoceptor blocking drugs lower blood pressure at the vascular 
membrane by selectively blocking receptor-operator calcium channels. This 
blockade inhibits the release of calcium ions from intracellular stores, 
maintaining a low level of tonic contraction in vascular tissue. Like adrenoceptor 
blockers, calcium antagonists interfere with the influx of extracellular calcium 
ions across the vascular membrane. Calcium channel blockers, however, have 
a voltage-dependent, as opposed to a receptor-dependent, mode of action 
(Reuter, 1983). The potency of these drugs appears to increase as membrane 
depolarization increases, as well as during repetitive stimulation (Reuter, 1983). 
The primary effect then, is a desensitizing of the vascular membrane to 
depolarization, requiring a greater level of stimulation for voltage-dependent 
calcium channel activation. Calcium antagonists do not appear to compete with 
calcium for vascular binding sites but, rather bind to sites that interfere with the 
channel gating mechanism (van Breemen, Lukeman, & Cauvin, 1984). Although 
it is presently unknown whether voltage-dependent channels function differently 
in hypertensives, research has indicated that a reduction of calcium influx 
brought about by antagonist administration tends to reduce the level of smooth 
muscle contractility and peripheral resistance (van Breemen et al., 1984). 
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In addition to adrenoceptor and calcium antagonists, diuretics, 
vasodilators, and angiotensin converting enzyme (ACE) inhibitors have also 
proven effective in the treatment of hypertension. These pharmacological 
regimens, however, are not without their drawbacks. There is potential in these 
drug therapies for additive and synergistic effects between antihypertensive 
drugs and for interaction between these drugs and other medications and 
dietary components (Lees & Reid, 1990). This potential for drug interaction is 
considerable in middle-aged and elderly individuals where antihypertensive 
drugs are widely used in long-term therapy (Lees & Reid, 1990). Research has 
indicated that when left ventricular function is markedly impaired, short- and 
long-term therapy with calcium channel blockers can increase cardiovascular 
morbidity and mortality (Packer, 1989). Inhibition of contractility of the smooth 
muscle of the gut and of atrioventricular conduction in the heart has also been 
shown with administration of the calcium antagonist verapamil (Lees & Reid, 
1990). There is also evidence that calcium antagonists can affect liver 
metabolism (Bauer et al., 1986). 
Other antihypertensive drugs such as beta-blockers and ACE inhibitors 
which interfere with neurohormonal activity, can favorably modify the long-term 
outcome of individuals with impaired left ventricular function (Packer, 1989), but 
can also result in adverse effects. Side-effects of beta-blockers include postural 
hypotension, fatigue, bradycardia, and reflex tachycardia (Loebl & Spratto, 
1983). Adverse reactions from the use of ACE inhibitors include gastric 
irritation, nausea, anorexia, constipation, and possible precipitous hypotension 
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when used in conjunction with diuretics (Loebl & Spratto, 1983). 
The effectiveness of antihypertensive drug therapy has been proven in 
both short- and long-term treatment of high blood pressure (van Breemen et alM 
1984; Lees & Reid, 1990). The financial outlay and potential for adverse side 
effects however, make non-drug therapies as alternative or component 
treatments attractive when choosing a means to regulate high blood pressure. 
Exercise and Blood Pressure 
Research has indicated that antihypertensive drug treatment of individuals 
with mild hypertension (defined as a persistent diastolic pressure between 90-
105 mm Hg) results in a significantly lower mortality and fewer cardiovascular 
complications than in individuals who do not receive drug treatment (Kaplan, 
1984). In spite of their proven effectiveness, however, the use of 
antihypertensive drugs in the treatment of high blood pressure has been 
brought into question with the increasing identification of individuals with mild 
hypertension in which drug-lowered pressure has not demonstrated the 
expected degree of protection against coronary heart disease, prompting 
renewed interest in alternative treatment methods (Kaplan, 1984). Reviews of 
antihypertensive drug therapies have indicated that they generally tend to make 
people feel worse, and that they can induce various biochemical aberrations 
(Kaplan, 1984). This has prompted the recommendation by an expert 
committee of the World Health Organization and International Society of 
Hypertension that non-drug therapies should be used for at least three months 
for individuals with diastolic pressures below 100 mm Hg and indefinitely for 
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those with diastolic pressures below 95 mm Hg (World Health 
Organization/International Society of Hypertension, 1983). 
Weight reduction, sodium restriction, potassium or calcium 
supplementation, relaxation, and exercise are a few of the current non-drug 
therapies for hypertension. Although therapies such as weight reduction, 
sodium restriction, and exercise have demonstrated significant pressure 
lowering effects in specific clinical trials, no one non-drug therapy has 
conclusively proven to result in lower blood pressure in all cases (Kaplan, 1984). 
The role of exercise as a viable antihypertensive therapy is not as established as 
that of therapies such as weight reduction and sodium restriction, as reflected 
by the varied results reported in the current literature (Fagard et al., 1990). 
In exploring the possible reasons for an effect of exercise on blood 
pressure, some basic factors should be reviewed. Since blood pressure is the 
product of cardiac output (heart rate times stroke volume) and total peripheral 
resistance (TPR), any intrinsic or extrinsic factors which alter heart rate, stroke 
volume, blood viscosity, or vascular smooth muscle tone and reactivity, will also 
affect blood pressure. Dynamic exercise, such as cycling and running, results 
in an increase in cardiac output and a decrease in TPR during exercise (Lamb, 
1984). It is possible that exercise training may modify hemodynamic responses 
such that this decrease in TPR persists after cessation of exercise, resulting in a 
concomitant decrease in resting blood pressure. It is also known that in a 
trained individual, resting heart rate decreases as a result of exercise training 
and resting stroke volume increases to maintain cardiac output at rest (Lamb, 
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1984). It is therefore conceivable that a decrease in resting blood pressure with 
exercise training may be due to a decrease in cardiac output as a result of a 
decrease in resting heart rate below the compensatory increase in stroke 
volume. Exercise training may therefore reduce resting blood pressure by either 
a reduction in cardiac output, TPR, or both. In a comprehensive review of 
cross-sectional and longitudinal exercise training studies by Tipton (1984), no 
conclusive support for the cardiac output theory was reported. The majority of 
investigators, therefore, have attempted to explain the effects of exercise training 
on blood pressure as a function of changes in TPR (Tipton, 1984). 
Significant reductions in blood pressure with exercise training have been 
reported in both hypertensive and normotensive subjects (Duncan et al., 1985; 
Kiyonaga et al., 1985; Saar, Chayoth, & Meyerstein, 1986; Seals & Hagberg, 
1984). Studies observing the long term effects of endurance exercise training 
(defined as greater than three months) in human subjects have reported 
decreases in systolic blood pressure ranging from 10.3-16.0 mm Hg in 
hypertensives (Boyer & Kasch, 1970; Cade et al., 1984; Choquette, & Ferguson, 
1973; Duncan et al., 1985; Nelson, Esler, Jennings, & Korner, 1986) and from 
4.0-6.3 mm Hg in normotensives (Choquette & Ferguson, 1973; Duncan et al., 
1985). Reported decreases in diastolic pressure ranged from 4.0-11.8 mm Hg 
in hypertensives (Boyer & Kasch, 1970; Choquette & Ferguson, 1973; 
Kukkonen, Rauramaa, Voutilainen, & Lansimes, 1982; Nelson et al., 1986) and 
from 2.0-6.0 mm Hg in normotensives (Boyer & Kasch, 1970; Choquette & 
Ferguson, 1973). Not all studies, however, have observed significant reductions 
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in blood pressure (Cleroux, Peronnet, & de Champlain, 1987; Deplaen & Detry, 
1980; Johnson & Grover, 1967). It is possible, however, that the conflicting 
results reported in the literature may be due to small sample sizes, pre-study 
fitness levels of the subjects, type or duration of the exercise regimen, or dietary 
factors. It has been suggested that in most cases, results of exercise training 
studies should be viewed with caution due to problems such as small sample 
sizes, poor study designs, methodological problems, limited use of adolescent 
and young adult populations, and differences in screening criteria (Seals & 
Hagberg, 1984). The inconclusive nature of this area of research makes it 
difficult to recommend the use of exercise training as a replacement for 
pharmological intervention in treatment of hypertension. Literature reviews of 
exercise training and blood pressure have suggested however, that while 
exercise training cannot replace pharmacological therapy in persons with 
sustained moderate-to-severe hypertension, it may be a benefical component of 
the therapy (Fagard et al., 1990; Seals & Hagberg, 1984). Additionally, exercise 
training may play an even greater role in the treatment of individuals with mild 
hypertension (Fagard et al., 1990; Seals & Hagberg, 1984). 
It has been suggested that the decreases in blood pressure observed 
with exercise training in certain studies are a consequence of a decrease in 
peripheral vascular resistance, possibly due to a decrease in sympathetic tone 
(Saar et al., 1988). This premise comes from research which has indicated that 
physical training significantly lowers the sympathetic response to dynamic 
exercise, and that activity and reactivity of the sympathetic system are higher in 
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labile hypertensive patients (Cleroux et al., 1987). Plasma catecholamine levels 
are generally regarded as indices of sympathetic activity. Thus, attempts to 
establish alterations in sympathetic activity as a possible mechanism for the 
reductions in blood pressure observed after exercise training have included 
measurement of catecholamine levels. Several studies utilizing dynamic 
exercise training in both normotensives and hypertensives have reported lower 
plasma norepinephrine levels in conjunction with lower blood pressure (Duncan 
et al., 1985; Jennings et al., 1986; Kiyonaga et al., 1985; Nelson et al., 1986; 
Urata et al., 1987). On the other hand, plasma epinephrine levels have been 
reported to be decreased in some studies (Hickson et al., 1979; Winder, 
Hagberg, Hickson, Ehsani, & McLane, 1978), and unchanged in others 
(Jennings et al., 1986; Nelson et al., 1986; Urata et al., 1987). Cleroux et al. 
(1987) observed no significant changes in either catecholamine levels or blood 
pressure in a group of labile hypertensives (n=12) upon completion of a 20 
week aerobic training program. Although some of the reported changes in 
blood parameters with exercise training may be associated with alterations in 
sympathetic function, alterations at the cellular level with exercise training and 
the identification of a specific mechanism remain to be established. 
Exercise. Calcium, and Blood Pressure 
While some studies have correlated alterations in the levels of circulating 
catecholamines with decreases in blood pressure after exercise training 
(Duncan et al., 1985; Kiyonaga et al., 1985), few have attempted to observe 
possible alterations in ionic parameters, specifically calcium. Since calcium 
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plays a critical role in the release of catecholamines from adrenergic nerves 
(Rubin, 1970) and in vascular membrane stabilization (Robertson, 1988), 
changes in the serum or cellular ionized calcium levels affecting the release of 
catecholamines, or membrane responsiveness to calcium channel activators 
may be a possible link between the suggested sympathetic response and 
reductions in blood pressure after exercise training. Along with increases in 
blood pressure observed during exercise, catecholamine levels increase (Lamb, 
1984), and this increased sympathetic activity leads to an increased influx of 
calcium ions into the vasculature resulting in the observed vasoconstriction. If 
the platelet is a good model for the vasculature, increases in intracellular 
calcium levels should be paralleled. 
Correlations between platelet intracellular calcium and blood pressure 
have been documented in several studies (Erne et al., 1984; Le Quan Sang & 
Devynck, 1986; Ueno et al., 1988), however, these studies only compared blood 
parameters and made no allowances for factors such as exercise or diet. Since 
a positive correlation between intracellular ionized calcium concentration and 
blood pressure has been reported, possibly due to alterations in the cell 
membrane, any decreases in blood pressure observed with exercise training 
should be mirrored by decreases in intracellular ionized calcium levels if 
peripheral smypathetic activity is involved. The few studies that have measured 
intracellular platelet calcium concentration after exercise have reported no 
significant changes in intracellular levels even though there were significant 
elevations in blood pressure, heart rate, and serum catecholamines (Barr et al., 
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1988; Haller et al., 1986). Although these studies indicate that intracellular 
platelet calcium concentrations do not parallel changes in vascular tension 
during acute bouts of exercise, there is no current research observing the long 
term effects of exercise training on blood pressure in conjunction with calcium 
parameters. Since different mechanisms are involved in acute and long term 
blood pressure regulation, longitudinal studies or cross-sectional studies 
measuring differences between trained and untrained individuals may 
demonstrate a correlation between intracellular platelet calcium concentrations 
and vascular tension not evident in studies observing relationships with acute 
exercise. Therefore, this study was designed to compare the differences in 
blood calcium parameters and blood pressure between trained and untrained 
normotensive, premenopausal females in order to assess possible relationships 
between exercise, blood calcium, and blood pressure. 
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CHAPTER III 
METHODS 
Sample Selection 
Forty-one female volunteers (mean age= 26.5, range 18-40) were 
recruited from the University of Virginia/Charlottesville area. Subjects were 
screened for participation on the basis of the following criteria: 
1) 18-40 years of age. 
2) Nonsmoker. 
3) No history of renal or hepatic disease, diabetes, or hypertension. 
4) No birth control medication for at least six months prior to testing. 
5) Mean blood pressure below 140/90 mm Hg. 
6) Within 15% of their ideal body weight as indicated by the 1983 
Metropolitian Life Height and Weight Tables. 
7) Running at least 20 miles/week, or less than 10 miles/week for the 
past six months. 
This study was approved by the Human Investigation Committee of the 
University of Virginia (HIC #3645). All volunteers were fully informed of the 
potential risks and benefits of the proposed research prior to giving their 
consent for participation. 
Program Design 
Subjects were divided into two groups based on their level of training. 
The trained group (n= 20, mean age= 27.5, range 18-40) consisted of women 
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running at least 20 miles per week consistently during the past six months or 
longer. The untrained group (n= 21, mean age= 25.6, range 18-40) included 
those women running no more than 10 miles per week or maintaining an activity 
level equivalent to this for the past six months. Activities of the untrained 
women included exercise such as one to two hours of aerobic dance 
class/week, one to one and a half hours of stationary cycling/week, or six to 
ten miles of walking or jogging/week. 
During the initial screening a personal medical history and a physical 
examination were obtained from each subject at the University of Virginia 
General Clinical Research Center (GCRC) by qualified medical personnel. The 
medical history and physical examination were used in determining whether or 
not the individual fit the physical qualifications for participation and as a basis for 
determination of menstrual cycle status. Classification of cycle status was 
based on the number of menstrual cycles, reported by the subject, for the 
previous year. Classification was as follows: 
1) Eumenorrheic - ten to twelve menses per year. 
2) Oligomenorrheic - three to nine menses per year. 
3) Amenorrheic - fewer than three menses per year. 
Oligomenorrheic and amenorrheic women were further tested to rule out the 
possibility of underlying reproductive function abnormalities or metabolic 
disorders. This testing included assessment for hyperprolactinemia, thyroid 
disorders, and excess androgens. Any subjects identified as having any of the 
aforementioned disorders were excluded from participation. The trained group 
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consisted of twelve eumenorrheic and eight oligomenorrhea (combined oligo-
and amenorrheic) women while all the women in the untrained group were 
eumenorrheic. Also, an explanation of the testing procedures and instruction on 
maintaining a seven-day food record, based on estimation of food consumption 
by household measures, were given at the initial visit. 
The testing occurred during two subsequent visits, one to the GCRC for 
blood pressure measurement and blood sampling, and one to the University of 
Virginia Exercise Physiology Laboratory for body composition analysis. Dietary 
food records were started on the day of the visit to the GCRC for testing and 
continued for seven consecutive days. These records were completed by the 
subjects on an individual basis and then collected. 
Blood Pressure Measurement and Blood Sampling 
Subjects were asked to return to the GCRC for testing, after an eight-
hour fast and at least a four hour abstention from caffeine, and prior to daily 
exercise regimens. All blood pressure measurements and blood sampling were 
conducted between the hours of 6:30 and 9:00 am. Upon arrival at the GCRC 
and in order to approximate resting conditions as closely as possible, subjects 
were placed in the supine position in a relaxed atmosphere for a ten minute 
period prior to testing. After this rest period three different blood pressure 
measurements were taken, with a two minute rest period between 
measurements. If three measurements were obtained with a difference of five 
mm Hg or less among them, the mean of the values was taken. If the three 
initial measurements yielded values with a greater than five mm Hg difference, 
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additional measurements were made until a mean of three values with a five mm 
Hg or less difference was obtained. The positioning, cuff application, time 
between measurements and number of measurements either met or exceeded 
the recommendations for blood pressure measurement by the British 
Hypertension Society (Petrie, O'Brien, Littler, & DeSwiet, 1986). 
Blood pressure measurements were made utilizing the Dinamap vital 
signs monitor, model 845XT (Critikon, Inc., Tampa, FL). This instrument is an 
indirect, noninvasive, automatic arterial pressure measurement device which 
utilizes a microprocessor controlled oscillometric method of measurement 
(Goldthorp, Cameron, & Asbury, 1986). In addition to measuring diastolic and 
systolic blood pressures, the Dinamap also measures mean arterial pressure 
and heart rate. 
Upon completion of the blood pressure measurement, a thirty milliliter 
(ml) venous blood sample was drawn from the anticubital vein by GCRC 
personnel. Twenty ml of this sample were immediately placed in a tube 
containing two ml of acid citrate dextrose (ACD) to prevent platelet aggregation. 
Approximately 15 microliters (ul) of the sample were drawn for hematocrit 
analysis. The 15 ul were drawn into two capillary tubes and then spun in a 
microcentrifuge (Damon/IEC Division, Needham Heights, Mass.) at 12,500 RPM 
for three minutes. The spun samples were then read using a micro-capillary 
reader (Damon/IEC Division, Needham Heights, Mass.) to obtain the hematocrit 
values. The remaining ten ml of sample were sent to the University of Virginia 
Medical Center's Clinical Chemistry Laboratory for analysis of the other required 
serum parameters. 
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Platelet and Serum Analysis 
Human platelet-rich plasma (PRP) was isolated from the twenty ml portion 
of the sample by a series of three, three to five minute centrifuge spins at 1500 
RPM. The platelets were then loaded with lndo-1 /AM, a Ca2+ binding 
fluorescent dye (Molecular Probes, Eugene, OR) according to the procedure 
outlined in Appendix A. Upon completion of the loading procedure, intracellular 
platelet ionized calcium concentration was measured using a Perkin-Elmer MPF-
44A fluorescence spectrophotometer (Perkin-Elmer Corp., Norwalk, CT) at 
emission wavelengths of 395 and 480 nm with an excitation wavelength of 335 
nm. The value yielded by a ratio of the emission amplitude at 395 nm over the 
emission amplitude at 480 nm, after correction for the unloaded sample blank, 
reflects the micromolar concentration of platelet intracellular ionized calcium. 
Analyses for serum total calcium, serum sodium, serum potassium, 
serum albumin and serum total protein were performed utilizing a Technicon 
SMAC continuous analyzer according the the methods outlined in Appendices 
B, C, D, E, and F, respectively. Serum total calcium adjusted for serum albumin 
concentrations was calculated according to the formula: modified total calcium 
(mmol/l) = total calcium (mmol/l) - 0.019 [ albumin (g/l) - 42], (where 42 g/l is 
the normal mean value of serum albumin) derived by Hvarfner et al. (1987). 
Analysis for serum ionized calcium was performed using a Nova 2 analyzer as 
outlined in Appendix G, and for serum magnesium using a Ektachem 700 
analyzer as outlined in Appendix H. 
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Body Composition Analysis 
Each subject's percent body fat was assessed by hydrostatic weighing at 
the University of Virginia Exercise Physiology Laboratory. An Accu-weigh beam 
scale (accurate to 0.1 kg) was first used to assess the subject's weight in air. 
Residual volume was measured prior to weighing underwater using the oxygen 
dilution technique described by Wilmore (1969). Underwater weight was 
measured at least five times with a Chatillion autopsy scale (accurate to 10 gm) 
at a water temperature of 37 degrees Celsius. An average of the last three of 
the five measurements was used as an estimate of the true underwater weight 
for the determination of body density (Katch, Michael, & Horvath, 1967). 
Percent body fat was then computed from the formula developed by Brozeck, 
Grande, Anderson, and Keys (1963). 
Dietary Analysis 
Subjects were instructed in the use of household measures to estimate 
food consumption. Seven-day food consumption records were analyzed 
utilizing the Nutripractor 6000 dietary analysis software package (Practorcare, 
Inc., CA). Values used for total kilocalories, protein, carbohydrate, fat, and 
calcium intake were an average of the seven-day food record analysis. 
Statistical Analysis 
Statistical analysis of the data was performed utilizing the CLINFO 
software system (BBN Software Products Corp., Cambridge, MA). Initial 
statistical analysis involved the use of the two-tailed Student's T-Test for 
unpaired observations. This analysis was performed between the trained and 
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untrained groups and between individuals in the trained group divided into two 
groups based on menstrual function (eumenorrheic, n=12 and oligomenorrheic, 
n=8). The Wilk-Shapiro test for normality was performed on all data sets prior 
to the performance of the Student's T-Test, all data tested was normally 
distributed. Correlations between variables were assessed with simple linear 
regression. Analysis of Covariance (ANCOVA), using regression models, was 
employed to assess the dependency of serum magnesium and of the calcium 
parameters on the serum albumin and total protein concentrations. ANCOVA 
was also used to assess the dependency of the blood pressure variables on 
heart rate. 
Although 22 separate t-tests were performed, it was determined that 
there was no problem of an inflated alpha level with the performed t-test 
statistics due to the high degree of association between the variables tested. 
For this reason no multiple comparison corrections were performed on the data. 
The level of significance for all statistical tests was set at 0.05. 
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CHAPTER IV 
RESULTS 
The characteristics of the study population are presented in Table 1. 
There were no significant differences between the groups for mean age, body 
weight, percent body fat, or hematocrit values. Resting heart rates in the 
trained women were significantly lower (p = 0.0005) than those of the untrained 
women. Heart rates for the combined group (n = 41) were positively correlated 
with mean arterial pressure (Figure 1) and with diastolic blood pressure (Figure 
2), but not with systolic pressure (not shown). Both mean arterial pressure and 
diastolic blood pressure in the trained group were significantly lower than those 
of the untrained group (p = 0.023 and p = 0.001, respectively). No difference 
in systolic blood pressure between the groups were noted. Using ANCOVA to 
control for the effect of heart rate revealed no significant differences in mean 
arterial pressure (Appendix I, Table 1-1) or systolic blood pressure (Appendix I, 
Table I-2) between the two groups. However, diastolic blood pressure remained 
significantly different (p = 0.012) between the two groups, with the trained 
group exhibiting a mean diastolic blood pressure that was lower than the 
untrained group by a mean of six mm Hg (Appendix I, Table I-3). 
The measured blood chemistry parameters for the trained and untrained 
subjects are listed in Table 2. The mean serum levels of potassium and sodium 
were similar in both groups. The serum magnesium levels of the trained group 
were significantly higher (p = 0.016) than those of the untrained group. 
Table 1. Mean (+. SEM) characteristics of trained and untrained women 
Characteristic Trained (n=20) Untrained (n=21) P-value 
Mean age (yr) 27.55 ± 1.64 25.62 + 1.53 0.39 
Body weight (kg) 57.45 ± 1.07 56.64 + 1.09 0.60 
Body fat (%) 21.90 ± 0.62 23.62 + 1.05 0.17 
Hematocrit (%) 37.52 ± 0.45 37.34 + 0.50 0.80 
Heart rate (beats/min) 57.70 ± 2.30 68.90 + 1.80 0.0005 
Mean arterial pressure 76.33 ± 1.29 80.53 ± 1.23 0.023 
(mm Hg) 
Mean diastolic pressure 61.64 ± 1.80 68.79 ± 0.80 0.001 
(mm Hg) 
Mean systolic pressure 108.05 J 11.64 111.45 ± 1.67 0.15 
(mm Hg) 
Note. Mean body weight values are within 10% of normal ranges, body fat, 
hematocrit, heart rate, and blood pressure values are all within normal 
established ranges. 
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Table 2. Mean (± SEM) blood chemistry measurements in trained and 
untrained women 
Parameter Trained (n=20) Untrained (n=21) P-value 
Serum potassium 4.15 ±0.09 4.14 ± 0.05 0.944 
(mEq/L) 
Serum sodium 140.1 ±0.4 140.5 ± 0.4 0.513 
(mEq/L) 
Serum magnesium 1.86 ±0.03 1.76 ±0.03 0.016 
(mg/100 ml) 
Serum albumin 4.77 ±0.15 4.20 ± 0.07 0.0001 
(g/100 ml) 
Serum total protein 7.17 ±0.62 6.61 ± 0.37 0.002 
(g/100 ml) 
Serum total calcium 9.68 ±0.10 9.41 ± 0.08 0.034 
(mg/100 ml) 
Adjusted serum total 0.813 ± 0.0002 0.814 ± 0.0002 0.166 
calcium (mmol/L)* 
Platelet ionized calcium 0.146 ±0.009 0.122 ±0.004 0.020 
(uM) 
Serum ionized calcium 4.96 ± 0.05 5.25 ± 0.03 0.0001 
(mg/100 ml) 
Note. All mean values are within normal established ranges for the given 
parameter. 
* - Adjusted serum total calcium (mmol/L) = total calcium (mmol/L) - 0.019 
[albumin (g/L) - 42] (where 42 is the normal mean value of serum albumin) 
(Hvarfner et al., 1987). 
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The trained women exhibited serum albumin and serum total protein 
concentrations that were significantly higher than their untrained counterparts (p 
= 0.0001 and p = 0.002, respectively). A significant negative relationship was 
observed between serum albumin concentration and diastolic blood pressure 
(Figure 3). Significant relationships were also present between serum albumin 
concentration and all of the measured blood calcium parameters (Figures 4-6). 
Positive relationships were observed between serum albumin and both serum 
total calcium and platelet ionized calcium concentrations (Figures 4 and 6, 
respectively). A significant negative association between serum albumin and 
serum ionized calcium concentration was also present (Figure 5). 
All of the measured blood calcium parameters were significantly different 
between the two groups. Serum total calcium and platelet ionized calcium 
concentrations were greater in the trained group (p = 0.034 and p = 0.02, 
respectively), while serum ionized calcium concentration was significantly higher 
in the untrained group (p = 0.0001). No significant correlations were observed 
between any of the individual blood pressure variables (diastolic, systolic, or 
mean arterial pressure) and the levels of serum total calcium, serum ionized 
calcium, platelet ionized calcium, serum magnesium, or serum total protein. 
Adjustment of the serum total calcium concentrations of the two groups 
for the effect of the serum albumin concentration removed the significant 
difference observed when the uncorrected total calcium concentrations were 
compared (Table 2). This occurred whether the serum albumin adjustment was 
calculated from the formula of Hvarfner et al. (1987), or computed statistically 
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using ANCOVA (Appendix I, Table 1-4). Using ANCOVA to adjust for the serum 
albumin concentration also removed the difference in platelet ionized calcium 
observed between the groups (Appendix I, Table 1-5). Serum ionized calcium 
concentration was significantly lower in the trained group whether unadjusted (p 
= 0.0001), adjusted for serum albumin concentration (p = 0.005) (Appendix I, 
Table I-6), or adjusted for serum albumin and total protein concentrations (p = 
0.0001) (Appendix I, Table I-7). 
The dietary intake values for calcium, total calories and the 
macronutrients are presented in Table 3. Mean dietary calcium intake was 
greater in the trained group by more than 250 mg per day (p = 0.006). When 
calcium intake was expressed as milligrams per 1000 kilocalories (kcal), intake 
between the groups was similar (503.4 ± 26.5 mg in the trained group vs. 457.9 
_+ 22.3 mg for the untrained group, p = 0.2). No significant correlations were 
observed between total dietary calcium intake and any of the blood pressure 
variables (diastolic, systolic, or mean arterial pressure), or between dietary 
calcium and platelet ionized, serum ionized, or total calcium. 
Total calorie intake, protein intake, and carbohydrate intake were 
significantly greater in the trained women (p = 0.008, p = 0.003, p = 0.002, 
respectively). No difference in fat intake between the groups was observed. 
Expressing protein, fat, and carbohydrate as percentages of the total calorie 
intake indicated that there was no difference between trained and untrained 
subjects in the percentage of calories from protein (14.8% vs. 14.9%), however, 
the untrained women received a higher percentage of their calories from fat 
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Table 3. Mean (± SEM) dietary intake values for trained and untrained women 
Dietary Parameter Trained (n=20) Untrained (n=21) P-value 
Calcium (mg) 979 ±78 711 ± 47 0.006 
Total calories (kcal) 1973 ± 130 1556 ± 68 0.008 
Protein (g) 72.8 ±3.9 57.9 ±2.3 0.003 
Fat (g) 62.3 ±5.3 61.0 ±3.1 0.830 
Carbohydrate (g) 271.3 ±22.8 186.0 ±8.3 0.002 
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(35.3% vs. 28.4%) and a lower percentage of their calories from carbohydrate 
(47.8% vs. 55.0%) than their trained counterparts. 
Since altered estrogen levels relating to menstrual function is reported to 
affect calcium absorption and excretion (Heaney, 1982), differences in menstrual 
function between groups might account for some of the significant results that 
were observed. All of the subjects in the untrained group were eumenorrheic 
(had normal menstrual function), however, only twelve of the trained group were 
eumenorrheic while the other eight had irregular function (oligomenorrheic and 
amenorrheic). Therefore, the trained group was split into two groups, 
eumenorrheic and oligomenorrheic (containing both the oligo- and amenorrheic 
subjects for the purpose of analysis), to determine if menstrual status could 
account for some of the observed differences between groups. Table 4 
contains the results of the comparison of the eumenorrheic and oligomenorrheic 
trained women. The trained women with normal function were significantly older 
(31.1 vs. 22.3 yrs., p = 0.002), had a lower percentage of body fat (21.0% vs. 
23.3%, p = 0.04), and a lower concentration of total calcium (9.52 vs. 9.94 
mg/100 ml, p = 0.02) than the trained women with irregular function. When 
total calcium concentrations were adjusted for the serum albumin concentration, 
the mean concentrations were no longer significantly different. No differences 
between these two groups of trained women were observed in any of the other 
blood pressure variables, serum parameters, or dietary intake parameters. 
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Table 4. Mean (± SEM) characteristics, blood chemistries, and dietary intake 
values for trained eumenorrheic vs. oligomenorrheic women 
Parameter Eumenorrheic Oligomenorrheic P-value 
(n=12) (n=8) 
Age (yr) 31.1 + 1.9 22.3 + 1.7 0.002 
Body weight (kg) 56.3 + 1.3 59.1 + 1.8 0.225 
Body fat (%) 21.0 + 0.8 23.3 + 0.7 0.043 
Hematocrit (%) 38.2 + 0.6 36.6 + 0.6 0.070 
Heart rate 60.4 ± 3.4 53.7 ± 2.2 0.117 
(beats/min) 
Mean arterial 77.7 ± 1.4 74.4 ± 2.3 0.252 
pressure (mm Hg) 
Diastolic blood 63.7 ± 2.1 58.5 ±3.1 0.177 
pressure (mm Hg) 
Systolic blood 109.4 ±2.2 106.1 ± 2.4 0.319 
pressure (mm Hg) 
Serum potassium 4.09 ±0.13 4.24 ±0.12 0.412 
(mEq/L) 
Serum sodium 139.9 ±0.5 140.4 ± 0.8 0.633 
(mEq/L) 
Serum magnesium 1.82 ±0.03 1.93 ±0.05 0.068 
(mg/100 ml) 
Serum albumin 4.67 ±0.12 4.93 ±0.10 0.120 
(g/100 ml) 
Serum total protein 6.96 ±0.15 7.48 ± 0.23 0.081 
(g/100 ml) 
Serum total calcium 9.52 ±0.12 9.94 ±0.11 0.018 
(mg/100 ml) 
Adjusted serum total 0.813 ± 0.0004 0.813 ± 0.0002 0.177 
calcium (mmol/L)* 
Platelet ionized 0.150 ±0.013 0.142 ±0.011 0.653 
calcium (uM) 
Serum ionized 4.98 ± 0.07 4.91 ± 0.08 0.508 
calcium (mg/100 ml) 
Dietary calcium 968 ± 48 996 ± 188 0.891 
(mg) 
Total calories 1915 ± 186 2059 ±176 0.582 
(kcal) 
Protein (g) 74.1 + 4.5 70.8 + 7.4 0.704 
Fat (g) 61.5 + 7.9 63.6 + 6.5 0.841 
Carbohydrate (g) 249.0 + 22.3 304.7 + 45.8 0.297 
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Note. Mean body weight values are within 10% of normal ranges, body fat, 
hematocrit, heart rate, blood pressure values, and blood chemistry values are 
within normal established ranges for the given parameter. 
* - Adjusted serum total calcium (mmol/L) = total calcium (mmol/L) - 0.019 
[albumin (g/L) - 42] (where 42 is the normal mean value of serum albumin) 
(Hvarfner et al., 1987). 
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CHAPTER V 
DISCUSSION 
The purpose of this study was to compare the blood calcium parameters 
and blood pressure variables of trained and untrained healthy women in order 
to assess possible relationships between exercise, blood calcium parameters, 
and blood pressure. Serum sodium, potassium, magnesium, albumin, and total 
protein, and dietary total calories, calcium, protein, fat, and carbohydrate, were 
also measured and assessed for possible differences between groups. 
Resting heart rate, mean arterial pressure, and diastolic blood pressure 
were significantly lower in the trained women. Since the groups were similar for 
the characteristics of age, body weight, and percent body fat, these results 
suggest a depressor effect of prior training on heart rate and blood pressure. 
The significantly lower resting heart rates observed in the trained women are in 
agreement with the literature on cardiovascular adaptations to training (Astrand 
& Rodahl, 1977; Fagard et al., 1990; Lamb, 1984; Tipton, 1984). It has been 
proposed that this training-induced decrease in heart rate is probably caused by 
increased activity of the parasympathetic nerves projecting to the heart from the 
regulatory centers in the brain (Astrand & Rodahl, 1977; Lamb, 1984), or by a 
decrease in the sensitivity of the heart to sympathetic neurotransmitters (Lamb, 
1984). Recent research suggests that training-induced decreases in heart rate 
may be due, in part, to both an increase in parasympathetic influence and a 
decrease in sympathetic influence, favoring parasympathetic dominance (Smith, 
76 
Hudson, Graitzer, & Raven, 1989). Changes in the electrical properties of the 
sinoatrial node causing it to slow the heart rhythm, independent of autonomic 
changes, have also been proposed (Lewis, Nylander, Gad, & Areskog, 1979). 
The proposed role of the sinoatrial node comes from the observation that a 
significantly lower resting heart rate is still present in trained versus untrained 
men when both sympathetic and parasympathetic impulses to the heart are 
blocked (Lewis et al., 1979). Changes in autonomic activity may be at least 
partly responsible for the training-induced decrease in resting heart rate, as may 
changes in the electrical properties of the heart; however, it has not been 
ascertained to what extent changes in heart rate affect blood pressure (Fagard 
et al., 1990). 
Significant decreases in systolic (Boyer & Kasch, 1970; Choquette & 
Ferguson, 1973; Duncan et al., 1985) and diastolic blood pressure (Boyer & 
Kasch, 1970; Choquette & Ferguson, 1973) have been reported with aerobic 
exercise training. The majority of the training studies in the literature have 
utilized male rather than female populations (Fagard et al., 1990). The 
significantly lower diastolic and mean arterial pressures observed in the trained 
women in this study suggest that training, defined here as running at least 20 
miles/week for at least the past six months, has a definite lowering effect on 
blood pressure in this population. 
Significant positive correlations were observed between resting heart rate 
and both mean arterial pressure and diastolic blood pressure. When heart rate 
was controlled for statistically, the significant difference in mean arterial pressure 
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between the groups disappeared. This suggests that the initial significance 
observed in mean arterial pressure may be related to the lower resting heart 
rates observed in the trained women. Since heart rate is one of the determining 
factors in cardiac output, this might mean that the decrease observed in mean 
arterial pressure is partially dependent on the effect of training on cardiac output 
as well as on peripheral vascular resistance. This, however, remains conjecture, 
since cardiac output was not measured in this study. After accounting for the 
effect of heart rate, the trained women maintained significantly lower diastolic 
pressure than the untrained women, indicating that the majority of the difference 
in diastolic pressure observed with training is independent of the training effect 
on the heart. If this premise is true, then it provides support for the theory that 
reductions in blood pressure observed with exercise training are more likely due 
to greater changes in total peripheral resistance than in cardiac output (Tipton, 
1984). 
It has been suggested that decreases in blood pressure observed with 
exercise training are a result of decreased sympathetic activity (Saar et al., 
1986). Using levels of circulating catecholamines as indices of sympathetic 
activity, several investigators have reported lower plasma norepinephrine levels 
in conjunction with lower blood pressure in trained subjects (Duncan et al., 
1985; Jennings et al., 1986; Kiyonaga et al., 1985; Nelson et al., 1986; Urata et 
al., 1987). Opioid peptides, also known to have a role in pressure regulation, 
have also been reported to be lower in subjects after training (Lobstein & Ismail, 
1989). A direct relationship between catecholamine release and plasma beta-
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endorphins has been suggested since endorphin binding sites exist in the 
adrenal medulla (Akil et al., 1984). Measurement of plasma catecholamines and 
beta-endorphins, therefore, might reflect alterations in sympathetic action on 
centrally located regulatory centers. Future research from animal studies, 
providing more information on alterations in central regulation with training and 
the relationship between centrally and peripherally circulating catecholamines 
and opiates, should clarify this area of pressure regulation. 
Peripherally, catecholamines alter the contractile state of the vasculature 
by altering the cytosolic concentration of ionized calcium in the smooth muscle 
cell (Rasmussen, 1983). Activation of alpha-1 receptors on the vascular cell 
membrane by catecholamines results in an increased influx of calcium ions into 
the cytosol, increasing activation of the contraction-coupling mechanism and 
vascular tension. Catecholamines are also known to activate beta-2 receptors 
on the vascular membrane resulting in a decrease in cytosolic ionized calcium 
concentration and vascular relaxation. However, the conditions under which 
sympathetic stimulation acts to increase or decrease vascular tension have not 
been firmly established. The one factor that has been established is that 
receptor activation by catecholamines, be they alpha-1 or beta-2 receptors, 
alters the intracellular ionized calcium concentration of vascular smooth muscle 
(Postnov & Orlov, 1984). Therefore, studies reporting associations between 
calcium indices and blood pressure suggest that these associations are 
evidence that some forms of hypertension are a result of dysfunctions in 
vascular cell calcium metabolism. Proposed membrane alterations include: 
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1. Dysfunction of the ionized calcium transport system in the plasma 
membrane of the smooth muscle cell, resulting in increased cytosolic 
ionized calcium concentrations and increased vascular tension (Postnov 
& Orlov, 1984). 
2. Dysfunction of the ionized calcium transport system in the plasma 
membrane of nerve cells, resulting in enhanced neurotransmitter release 
and altered synaptic transmission of impulses (Postnov & Orlov, 1984). 
3. Alterations in the vascular membrane changing both its sensitivity and 
reactivity to the action of catecholamines and other vasoactive 
substances (Postnov & Orlov, 1984). 
All of the proposed alterations would lead to an increase in intracellular ionized 
calcium concentrations, resulting in an increase in vascular tension. Significant 
elevation of platelet intracellular ionized calcium levels has been reported to be 
positively correlated with both systolic and diastolic blood pressure in 
hypertensives (Erne et al., 1984; Hvarfner et al., 1988; Le Quan Sang & 
Devynck, 1986; Ueno et al., 1988). Significant associations between serum 
ionized calcium, total calcium and blood pressure have also been reported in 
hypertensives (Folsom et al., 1986; Strazzullo et al., 1983) and in normotensives 
(Hvarfner, Ljunghall, Morlin, Wide, & Bergstrom, 1986). A relationship between 
serum ionized and intracellular ionized calcium was proposed by McCarron 
(1982), who suggested that lower levels of serum ionized calcium would result in 
increased intracellular ionized calcium concentrations through a membrane 
destabilizing effect. This theory is supported by Hvarfner et al. (1988) who 
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reported correlations between lower levels of serum ionized calcium and higher 
levels of platelet ionized calcium and blood pressure in non-treated 
hypertensives. Based on the reported association between calcium and blood 
pressure in the literature, and the effect of sympathetic activity on the 
vasculature, it was hypothesized that significant differences in blood pressure 
between trained and untrained individuals would be paralleled by significant 
differences in blood calcium parameters. This hypothesis assumes that the 
effect of training is manifested in alterations of the action of catecholamines and 
other vasoactive substances on the peripheral vasculature. Significant 
differences observed between the groups for blood pressure were in the 
hypothesized direction, with the trained group demonstrating the lower mean 
arterial pressures and lower diastolic blood pressures. The significant 
differences observed in serum and platelet ionized calcium, however, were 
opposite of that expected. Based on the literature, it was expected that the 
group that exhibited the lower blood pressures would also have the lower 
intracellular and higher extracellular ionized calcium concentrations. The trained 
women, with the lower blood pressure variables, exhibited lower serum ionized 
and higher platelet ionized calcium concentrations than the untrained women, in 
contrast to the results reported in the literature (Bruschi et al., 1985; Erne et al., 
1984). Although the results of this study support the fact that there is an 
association between serum and intracellular ionized calcium levels (McCarron 
1982), they do not support the proposed direction of the associations between 
ionized calcium levels and blood pressure. Since the studies that reported this 
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association between ionized calcium levels and blood pressure utilized 
hypertensive populations (Bruschi et al., 1985; Erne et al., 1984; Hvarfner et al., 
1988), one possible explanation is that this association may be a result of rather 
than a cause of elevated blood pressure. Another possibility is that training 
level has a pressor effect on blood pressure that is independent of peripheral 
alterations in the calcium-dependent, vascular contraction-coupling mechanism. 
This training-induced depressor effect on blood pressure may therefore be due 
to either central regulatory changes or alterations in the autoregulatory process 
which do not rely on changes in vascular cytosolic calcium concentrations to 
produce vasodilation. 
No significant correlations were found between any of the calcium 
parameters and systolic, diastolic, or mean arterial pressure, which agrees with 
the results reported by Shore and associates (Shore, Booker, Sagnella, 
Markandu, & MacGregor, 1987). Several studies have reported a significant 
positive relationship between intracellular ionized calcium concentrations and 
blood pressure (Bing et al., 1986; Bruschi et al., 1985; Erne et al., 1984). 
According to the multivariate statistical model of Hvarfner et al. (1988), the 
platelet ionized calcium concentrations explained only five percent of the 
variability in mean arterial pressure, with serum parathyroid hormone 
concentration, serum ionized calcium concentration, and body mass index all 
influencing the relationship between platelet ionized calcium and blood pressure 
(Hvarfner et al., 1988). From these results the authors concluded that smooth 
muscle contraction may be, but is not necessarily, related to platelet ionized 
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calcium levels. Questions about the relationship between platelet ionized 
calcium concentration and blood pressure have also been raised in studies in 
which the effects of acute bouts of exercise on blood pressure and platelet 
ionized calcium levels were observed (Barr et al., 1988; Haller et al., 1986). 
Both of these studies reported significant increases in blood pressure, plasma 
lactate, and plasma catecholamines without differences in platelet ionized 
calcium levels from those prior to the exercise bout. Therefore, Barr et al. 
(1988) suggested that the rapid changes which presumably occur in ionized 
calcium concentrations of the smooth muscle cell and accompany physiological 
alterations in blood pressure are not reflected in platelet ionized calcium 
concentrations. Haller et al. (1986), who also measured platelet ionized calcium 
levels in conjunction with acute exercise, pointed out that the increase in blood 
pressure in their study was short-term and that their results did not account for 
platelet receptor binding or platelet membrane alterations. The results of these 
studies raise the possibility that either the platelet is not an adequate model for 
the smooth muscle cell or that the platelet is a sufficient model in the resting 
state but not during exercise. If the platelet is accepted as an adequate model, 
then these results suggest that the pressor effect of training on blood pressure 
is probably due to central or autoregulatory alterations. 
Reports on a relationship between serum ionized calcium and blood 
pressure are varied, with some investigators reporting an inverse relationship 
(Hvarfner et al., 1988), and others indicating a positive relationship (Fogh-
Andersen et al., 1984; Shibata et al., 1987). Hvarfner et al. (1988) suggested 
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that the inverse relationship they observed between serum ionized calcium and 
blood pressure, independent of platelet ionized calcium and serum parathyroid 
hormone concentrations, indicated a direct interaction between serum ionized 
calcium and blood pressure regulation. Robertson (1976), in a review of 
measurement procedures for ionized calcium, indicated that there are many 
factors which may alter measured calcium values. Primary among these are the 
effect of inactivity and alterations in the pH of the sample. Robertson (1976) 
states in his review that long-term inactivity, such as bedrest, produces changes 
in both serum total and ionized calcium concentrations, probably due to an 
induced imbalance between the rates of bone formation and resorption caused 
by the absence of weight-bearing activity. Inactivity reportedly produces an 
elevation in the serum ionized calcium fraction and a concomittent increase in 
total calcium levels (Robertson, 1976). Those studies, observing the 
relationship between blood pressure and blood calcium, reporting 
measurements of serum ionized calcium, did not account for activity level 
(Fogh-Andersen et al., 1984; Hvarfner et al., 1988; Shibata et al., 1987). 
Additionally, in studies which assessed the effect of exercise on ionized calcium, 
only measurements of intracellular ionized calcium were reported (Barr et al., 
1988; Haller et al., 1986). Therefore, it is possible that the level of activity in the 
trained group in this study was sufficient to depress the concentration of serum 
ionized calcium if activity level indeed has a depressor effect on serum ionized 
calcium levels. Robertson (1976) also reported that any loss of carbon dioxide 
from the sample during analysis would result in a rise in the pH of the sample 
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and a fall in the level of serum ionized calcium. Therefore, the pH of both serum 
and platelet ionized calcium samples in the present study was maintained 
between 7.2-7.4. A failure to maintain the serum sample at a pH of between 
7.2-7.4 during measurement may be a reason for the varied results in the 
literature. 
The higher total calcium and lower serum ionized calcium concentrations 
in the trained group suggest that there were alterations in the levels of the 
protein-bound and complexed calcium fractions. No mention of these fractions 
was made in many of the studies previously cited (Barr et al., 1988; Erne et al., 
1984; Haller et al., 1986; Hvafner et al., 1988). Correction of the serum total 
calcium concentration for serum albumin in the combined qroup, by the formula 
of Hvarfner et al. (1987) or by ANCOVA negated the significant difference initially 
observed between the groups. Since albumin is the principle blood protein to 
which calcium binds, this suggests that the protein-bound calcium fraction is 
higher in the trained group. Positive (Butler et al., 1984; Shibata et al., 1987) 
and negative (Pottgen & Davis, 1977) relationships between serum ionized 
calcium and serum albumin have previously been reported. A significant 
negative correlation between serum ionized calcium and serum albumin, and a 
significant positive correlation between platelet ionized calcium and serum 
albumin was observed in this study. These correlations suggest that as albumin 
concentration increases, there is an increase in the extracellular binding of 
calcium to albumin, lowering the concentration of the serum ionized calcium 
fraction, which, if McCarron's hypothesis is correct, results in a destabilization of 
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the vascular membrane and an increased intracellular ionized calcium 
concentration. Zaloga, Willey, Tomasic, and Chernow (1987), reported that as 
free fatty acid levels in the blood increase, serum ionized calcium levels 
significantly decrease. Free fatty acids are carried on the albumin molecule 
along with calcium. Therefore, Zaloga et al. (1987) suggested that variations in 
serum free fatty acid concentration may alter calcium binding, lowering serum 
ionized calcium concentrations by chelating calcium ions. Thus, differences in 
the blood concentration of free fatty acids between the groups might support 
the premise of increased binding of the protein-bound calcium fraction. 
An interesting finding was that serum ionized calcium concentrations 
remained significantly lower in the trained group even after adjustment for serum 
albumin concentration removed the significant differences observed between 
groups for serum total calcium and platelet ionized calcium concentrations. This 
finding suggests that there are alterations in the calcium fractions of the blood 
that cannot be accounted for by increased binding of calcium by albumin. This 
might indicate an increased binding of ionized calcium by the complexed 
fraction, whose activity in biological mechanisms is as yet undetermined. 
Regardless of which serum fraction contains the calcium, the findings of this 
study indicate that there is an increased concentration of calcium in the blood of 
trained individuals, possibly due to increased mobilization from bone, increased 
intestinal absorption, or decreased membrane binding of the calcium ions. 
Haigh, Fruin, Pinn, and Lea (1988) reported that distance running affects the 
fatty acid composition of membrane lipids in both platelets and erythrocytes, 
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which could possibly affect the ability of the membrane to bind calcium. 
Decreased membrane binding of calcium ions and alterations in the serum 
calcium fractions so that membrane permeability to calcium ions is increased is 
a possible explanation for the increased platelet ionized calcium levels observed 
in the trained women in this study. Measurement of the calcium mobilizing 
hormones, parathyroid hormone and 1,25 dihydroxycholecalciferol, the levels of 
membrane bound calcium, and the concentration of calcium in each of the three 
serum calcium fractions will help to identify the alterations in blood calcium 
fractions that may be induced by training. 
Heaney (1982) reported that lowered estrogen levels, such as those 
found in altered menstrual function, affects calcium absorption and excretion, 
thus differences in menstrual status might affect the concentration of the calcium 
fractions in the blood. Only eight of the trained women demonstrated irregular 
menstrual function, and when compared to those trained women with normal 
function, no significant differences were observed in any of the blood pressure 
variables, dietary variables, or blood chemistry indices, with the exception of 
total calcium, which, when corrected for serum albumin, lost its significance. 
This suggests that menstrual function does not confound the results obtained 
for the blood pressure and blood calcium parameters in this study. However, 
the sample sizes observed here may have been too small to demonstrate 
conclusive differences. 
Endurance training reportedly causes an approximately eight percent 
increase in resting blood volume, due primarily to an increased retention of 
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plasma proteins, specifically albumin (Lamb, 1984). The increased 
concentration of plasma proteins is due to an increased delivery of proteins 
from the lymph and a decreased loss of proteins from the plasma to the tissues 
(Lamb, 1984). This would explain the greater serum concentrations of total 
protein and albumin observed in the trained women. It might also be an 
indication of a training-induced alteration in the autoregulatory mechanism of 
capillary fluid shift. 
A significant inverse correlation was observed between serum albumin 
concentrations and diastolic blood pressure, with no relationship present 
between serum total protein and blood pressure. This conflicts with the results 
of Shore et al. (1987), who reported a positive correlation between total protein 
and both systolic and diastolic blood pressure, but no correlation between any 
of the three calcium fractions (protein bound, complexed, and ionized) or 
albumin with blood pressure. Increased concentrations of serum albumin and 
total protein are related to increases in resting blood volume observed with 
endurance training (Lamb, 1984). Although mean hematocrits were not 
significantly different between the two groups, this only accounts for the 
percentage of red blood cells present, and does not identify alterations in 
plasma volume. Measurements of plasma volume, therefore, might help to 
clarify the observed association between serum albumin and diastolic blood 
pressure. 
No differences were observed in the serum sodium and serum potassium 
concentrations between the groups. This suggests that these ions were 
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probably not confounding factors in the differences observed in blood pressure 
and blood calcium parameters between the groups. Serum magnesium 
concentrations, however, were significantly higher in the trained women. 
Magnesium can function as a calcium-channel blocker, modulating calcium-
channel activity and resulting in vasodilation (Resnick, 1990). Increased levels 
of serum magnesium reportedly blunt agonist-induced vascular contractions, 
while intracellular magnesium ions compete with calcium ions in the cytosol for 
calcium binding sites (Resnick, 1990). The increased levels of serum 
magnesium reported here may therefore have a role in the observed decrease 
in diastolic blood pressure through its action as a calcium channel blocker. 
Additionally, the increased serum levels of magnesium may reflect increased 
intracellular magnesium concentrations, which, through competitive blockade, 
may help to explain the increased platelet ionized calcium concentrations 
observed in the trained group. 
The two groups were homogenous for age, body weight, and percent 
body fat. Since there were no significant differences in body weight or percent 
body fat between the groups, it may be assumed that the increased caloric 
intake of the trained group is related to their increased energy expenditure. It 
would also follow that there would be an increased intake of macronutrients to 
meet the increased caloric intake. This would explain the increased protein and 
carbohydrate intake of the trained women. The calcium intakes of the trained 
group were significantly greater than that of the untrained group. Both groups 
were close to the recommended daily allowance (RDA) intake of 800 mg/day, 
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with the mean value for the trained group being higher (979 ± 78 mg/day), and 
that of the untrained group lower (711 +. 47 mg/day) than the RDA. Expressing 
the calcium intake as milligrams per 1000 kcal instead of a daily total indicated 
that the groups were similar in their calcium intake on a per 1000 kcal basis. 
Thus, the higher calcium intakes in the trained group is due to the higher caloric 
intake. 
No correlations were observed between dietary calcium intake and any 
blood pressure or blood calcium parameter, or serum albumin. Studies which 
have reported significant associations between blood pressure and dietary 
calcium have primarily been supplementation studies where one to one and a 
half grams of calcium were added to the subject's diet (Belizan et al., 1983; 
Johnson et al., 1985; McCarron & Morris; 1985). This would result in a 
doubling or possibly a tripling of the intake compared to the RDA. Since in 
calcium supplementation studies it has been reported that significant decreases 
in blood pressure occur in hypertensives (Johnson et al., 1985; McCarron & 
Morris, 1985), and in normotensives (Belizan et al., 1983), and no associations 
between dietary calcium and blood pressure were observed in this study, it is 
suggested that the level of calcium intake necessary to induce a hypotensive 
effect is probably at least double the RDA. Establishment of the dietary calcium 
level necessary for this effect is an area for future research. 
The percent of calories derived from each macronutrient indicated that 
each group received approximately 15 percent of their calories from protein, and 
that the untrained group received a higher percentage of their calories from fat 
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and a lower percentage from carbohydrate than their trained counterparts. It 
has been reported that increasing the protein content of the diet increases 
urinary calcium excretion (Schaafsma, 1988). Since there were no differences 
between the groups in the percent of calories derived from protein, it is unlikely 
that the protein content of the diet could have significantly affected the serum 
calcium fractions. However, measurement of urinary calcium would be 
necessary before it could be concluded that dietary protein was not a 
confounding factor. 
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CHAPTER VI 
SUMMARY AND RECOMMENDATIONS 
In comparing the blood calcium parameters and blood pressure variables 
in trained and untrained normal women, it was hypothesized that the trained 
women would exhibit lower blood pressure values which would be associated 
with higher serum ionized and lower platelet ionized calcium concentrations and 
higher dietary calcium intakes. The results of this study suggest a definite 
pressor effect of training on blood pressure but failed to establish any 
relationship between alterations in blood calcium parameters and blood 
pressure, despite significant differences in the blood calcium parameters 
between the two groups. 
The complexity of blood pressure regulation involving integration of 
central and peripheral control of specific brain centers, the heart, the kidneys, 
and the peripheral vasculature, make it hard to identify all of the pathways that 
training affects. From a hemodynamic standpoint, decreases were observed in 
resting heart rates, mean arterial pressures, and diastolic blood pressures in the 
trained women. Measurements of cardiac output, plasma volume, and total 
peripheral resistance are needed to identify their contributions to the observed / 
decreases in blood pressure. 
The significant correlations between serum albumin and the blood 
calcium parameters, the observed differences in blood calcium parameters 
between the groups, and the significantly higher serum total calcium 
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concentrations observed in the trained women suggest that training alters the 
composition of the calcium fractions in the blood. The results further suggest 
that measurements of all three calcium fractions (protein bound, complexed, 
and ionized) should be made before any associations are drawn between blood 
calcium indices and other parameters, such as blood pressure. 
Controlled feeding studies, manipulating the levels of calcium intake, may 
identify a relationship between dietary calcium and blood pressure, or between 
dietary calcium and blood calcium parameters. The present study, with no 
dietary controls, failed to demonstrate any hypotensive effect of calcium intakes 
close to the RDA, or any relationship between calcium intake and blood calcium 
parameters. 
This study, although failing to identify a relationship between training-
induced changes in blood pressure and altered blood and cellular calcium 
metabolism, has identified several directions for future research in the area of 
training, blood pressure, and calcium metabolism. Measurement of the 
hemodynamic parameters of cardiac output, total peripheral resistance, and 
plasma volume, in conjunction with measurements of opiate and catecholamine 
concentrations should help to identify whether central or peripheral actions play 
a greater role in training-induced hypotension. Studies observing the 
relationship between calcium mobilizing hormones, serum proteins, and serum 
calcium fractions, should help identify the mechanisms involved in the effect of 
training on calcium metabolism. Likewise, studies measuring calcium fraction 
binding and cell membrane binding will help to identify how training may affect 
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calcium binding kinetics and may further help to establish the role of 
magensium, which is in competition with calcium for binding sites. 
The establishment of the hemodynamic and blood chemistry alterations 
in response to training in individuals without defects in their blood pressure 
regulating systems will hopefully provide the medical profession with the 
knowledge necessary to utilize exercise training, either by itself or in conjunction 
with pharmacological therapy, as a viable treatment for hypertension. 
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INDO-AM LABELING: 
PLATELET WASHING PROCEDURE 
1. Platelet Preparation 
a. To the PRP add extra ACD, @ 0.5ml/10 ml PRP. 
b. Then add apyrase (Grade VII stock = 1 mg protein/ml saline) 
@ 20 ul/ml PRP. 
c. Then add PGI2 (stock = 1 mg/ml glycine buffer) @ 0.3 ul/ml PRP. 
d. Then add indomethacin (stock = 1 mg/ml ETOH) @ 1 ul/ml PRP. 
e. Then add indo-1/AM (stock = 1 mM in dry DMSO) @ 2.5 ul/ml PRP. 
f. Mix by swirling. Gas with air/C02 (95% to 5% ratio) and then cap 
tube. 
2. Incubate for 30 minutes at 37°C, in a shaker bath for the first 20 min 
standing for the last 10 min. Let stand at 25°C if desired. 
3. Centrifuge 20 minutes @ 2000 RPM. 
4. Suspend pellet in 1/2 volume warm ACD containing albumin (fatty acid-free 
BSA) @ 0.003 g/ml ACD and apyrase @ 20 ul/ml ACD. (Add apyrase just 
prior to resuspension). 
5. Centrifuge 20 minutes @ 2000 RPM. 
6. Make up Eagle's/HEPES medium; for 10ml final volume: Eagle's Salts = 
0.096 g, NaHC03 = 0.0176 g, HEPES buffer = 0.012 g, Albumin = 0.03 g 
Dissolve Eagle's salts, HEPES, NaHC03l and albumin in deionized water. Use 
0.1 N NaOH and 0.1N HCI to adjust final pH to 7.2 - 7.4, add deionized water to 
make up final volume (10 ml), gas with air/C02 (95% to 5% ratio) and cap. 
7. Bring up pellet in warm Eagle's/HEPES medium (37° C)adding hirudin 
(stock = 20 units/ml saline) @ 5 ul/ml PRP. 
8. Cover Platelet-rich Eagle's solution (PRE) with foil and let sit at 25°C for 1 
hour. 
9. Incubate PRE for 15-30 minutes at 37°C. Just prior to measurement, 
centrifuge a 2 ml aliquot of PRE for 5 minutes at 12,000 RPM. Use 
supernatant (PPE) for blank in spectrofluorimeter. 
10. Immediately measure emission of PRE and PPE. 
Perkin-Elmer: Excitation = 335 Emission = 395/480 
Reference: Gear, A. R. L. (1982). Rapid reactions of platelets studied by a 
quenched-flow approach: Aggregation kinetics. Journal of Laboratory and 
Clinical Medicine. 100. 866-886. 
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Test: Calcium 
Methodology: Calcium when mixed with the metal complexing dye 
cresolphthalein complex one in an alkaline medium will produce a pink colored 
calcium dye complex with a maximum absorbance at 570 nm. Initially a solution 
of HCI and 8-hydroxyquinoline is added to release protein bound calcium and 
bind free magnesium ions respectively. The free calcium ions are then dialyzed 
across a semipermeable (type H) membrane into a stream containing 
cresolphthalein complex and additional 8-hydroxyquinoline. Lastly, diethylamine 
is added as a color intensifies 
Protein bound calcium + HCI— > Free Calcium 
Free Calcium + 8-hydroxyquinoline—> Free Calcium + Magnesium-8-OH 
complex 
Free Calcium + cresolphthalein complex one + diethylamine—> calcium dye 
complex (abs @ 570 nm) 
Sample: only serum or heparinized plasma 
Sample Size: 700 ul 
Reagents: 8-hydroxyquinoline, cresolphthalin complex one, diethylamine 
Equipment: Technicon SMAC continuous analyzer 
Measurement Tvoe: endpoint 630 nm 
Expected Values: 8.5 -10.5 mg/dl 
Critical Values: <6.0, >13.0 mg/dl 
Dilutions: Any samples greater than 15.0 mg/dl should be diluted with 
deionized water or saline (9% NaCI) to a level less than 15.0 mg/dl and 
reanalyzed. 
Interferences: Calcium Salts in tap water increase values. Filter paper can 
contain high calcium concentrations, do not filter reagents. Oxalates 
coprecipitates calcium with sodium, potassium, and magnesium and will 
decrease values. 
Special Procedures and Comments: 
1. Anticoagulants other than heparin are unacceptable for analysis. 
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2. Calcium reagents have been known to deteriorate tubing. Calcium channel 
tubing must be replaced periodically. 
3. Calcium samples are analyzed in triplicate with the Medlab computer 
selecting the median value when three results are received, the mean when only 
two results are received, and the single result when only one result is received. 
Reference: Kaplan, A., Szabo, L. L., & Opheim, K. E. (Eds.). (1988). Clinical 
chemistry: interpretation and techniques. 145-350. Philadelphia: Lea & 
Febiger. 
APPENDIX C 
MEASUREMENT OF SERUM SODIUM 
118 
Test: Sodium 
Methodology: In the SMAC II the sodium and potassium channels are 
combined into one cartridge utilizing a common reference electrode. The 
sample is mixed with sodium potassium buffer and flows past the glass 
membrane of the sodium ion-selective electrode. Changes in the concentration 
of sodium cause changes in the electrical potential that exists between the 
ionically variable outer surface and the ionically constant inner surface of the 
sodium electrode. These changes are automatically measured against the 
potential of the reference electrode. The resulting difference in signal are 
processed by the computer to determine the sodium concentration. The 
computer calculates the concentration using the Nernst equation, which states 
that the potential difference between indicator and reference electrodes is 
proportional to the logarithm of the activity of the measured ion. 
Sample: only serum or heparinized plasma 
Sample Size: 700 ul 
Reagents: Sodium potassium buffer, electrode filling solution, and sodium ISE 
etching solution 
Equipment: Technicon SMAC continuous analyzer 
Measurement Type: potentiometric 
Expected Values: 136-145 mEq/L 
Critical Values: <120, >160 mEq/L 
Dilutions: Any samples greater than 160 mEq/L should be analyzed on the 
Astra and the Astra value reported. No sodium dilutions are to be run on the 
SMAC II. 
Interferences: None known. 
Special Procedures and Comments: None. 
Reference: Kaplan, A., Szabo, L. L., & Opheim, K. E. (Eds.). (1988). Clinical 
chemistry: interpretation and techniques. 145-350. Philadelphia: Lea & 
Febiger. 
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Test: Potassium 
Methodology: In the SMAC II the sodium and potassium channels are 
combined into one cartridge utilizing a common reference electrode. The 
potassium measurement utilizes a potassium selective valinomycin based 
electrode which is an excellent complexing agent for potasium. The sample is 
mixed with sodium potassium buffer and flows past the glass membrane of the 
potassium electrode. Changes in the concentration of potassium cause 
changes in the electrical potential that exists between the ionically variable outer 
surface and the ionically constant inner surface of the sodium electrode. These 
changes are automatically measured against the potential of the reference 
electrode. The resulting difference in signal are processed by the computer to 
determine the sodium concentration. The computer calculates the 
concentration using the Nernst equation, which states that the potential 
difference between indicator and reference electrodes is proportional to the 
logarithm of the activity of the measured ion. 
Sample: only serum or heparinized plasma 
Sample Size: 700 ul 
Reagents: Sodium potassium buffer, electrode filling solution, and sodium ISE 
etching solution. 
Equipment: Technicon SMAC continuous analyzer 
Measurement Type: potentiometric 
Expected Values: 3.5-5.0mEq/L 
Critical Values: <2.5, >6.0 mEq/L 
Dilutions: Any samples greater than 10.0 mEq/L should be analyzed on the 
Astra and the Astra value reported. No potassium dilutions are to be run on the 
SMAC II. 
Interferences: False elevations of potassium are caused by the ammonium ion. 
Special Procedures and Comments: 
1. Hemolysis will increase potassium in serum. Specimens with slight 
hemolysis can be analyzed but specimens with moderate or gross hemolysis 
should not have potassium values reported. 
Reference: Kaplan, A., Szabo, L. L., & Opheim, K. E. (Eds.). (1988). Clinical 
chemistry: interpretation and techniques. 145-350. Philadelphia: Lea & 
Febiger. 
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Test: Albumin 
Methodology: Albumin when mixed with a buffered solution of bromcresol 
green (BCG) will yield an albumin-BCG complex which absorbs light at 630 nm. 
The reaction is monitored approximately 1 minute after sample addition for 
absorbance of the complex at 630 nm. 
Albumin + BCG — > Albumin-BCG complex (abs. @ 630 nm) 
Sample: only serum or heparinized plasma 
Sample Size: 700 ul 
Reagents: BCG reagent 
Equipment: Technicon SMAC continuous analyzer 
Measurement Type: endpoint 630 nm 
Expected Values: 3.0 - 5.2 g/dl 
Critical Values: None 
Dilutions: Any samples greater than 6.0 g/dl must be diluted with water or 
saline (.9% NaCI) to a level less than 6.0 g/dl and reanalyzed. 
Interferences: Sodium flouride > 500 mg/dl; Transferrin > 500 mg/dl; 
Triglycerides > 300 mg/dl 
Special Procedures and Comments: 
1. Samples for only albumin or samples > 700 ul in volume should be analyzed 
on the RA-1000. 
2. No body fluids other than serum or plasma should be analyzed on the 
SMAC II. 
Reference: Kaplan, A., Szabo, L. L., & Opheim, K. E. (Eds.). (1988). Clinical 
chemistry: interpretation and techniques. 145-350. Philadelphia: Lea & 
Febiger. 
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Test: Total protein 
Methodology: Total protein is analyzed in the SMAC II by the Biuret reaction 
utilizing both a test and a blank measurement by two separate channels. In the 
test channel, sample is added to a stream of biuret reagent. The biuret reagent 
contains copper sulfate, the copper from which combines with the protein in the 
sample to produce a purple color. Also contained in the reagent are sodium 
potassium tartrate, a complexing agent, and potassium iodine to prevent auto 
reduction. In the blank channel, the sample is added to total protein blank 
solution which contains all of the constituents of biuret reagent with the 
exception of the copper sulfate and sodium potassium tartrate. Without these 
two reagents the biuret reaction does not occur and the absorbance measured 
is predominatly due to endogenous serum pigments. The absorbance of each 
channel is determined at 550 nm with the blank subtraction performed by 
differential colorimetry. 
Sample: only serum or heparinized plasma 
Sample Size: 700 ul 
Reagents: Biuret reagent, Total protein blank solution 
Equipment: Technicon SMAC continuous analyzer 
Measurement Type: endpoint blank corrected 550 nm 
Expected Values: 6.0 - 8.5 g/dl 
Critical Values: None 
Dilutions: Any samples greater than 10.0 g/dl must be diluted with water or 
saline (.9% NaCI) to a level less than 10.0 g/dl and reanalyzed. 
Interferences: Dextran infusions and hemolysis - increase values; ammonium 
ions - decrease values. 
Special Procedures and Comments: None 
Reference: Kaplan, A., Szabo, L. L., & Opheim, K. E. (Eds.). (1988). Clinical 
chemistry: interpretation and techniques. 145-350. Philadelphia: Lea & 
Febiger. 
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Test: Ionized Calcium 
Principle: The Nova 2 Ionized Calcium Analyzer combines an ion selective 
electrode, microcomputer-based electronics, and a simple analytical approach 
to provide a practical procedure for the measurement of ionized calcium in 
plasma, serum, or whole blood. The calcium and reference electrodes are a 
straight-tube design allowing the sample to flow straight through the electrode. 
The calcium electrode uses an immobilized liquid membrane, while the 
reference electrodes provide continuous flow of both reference solution and 
measured solutions (standards and samples). The electrical potential from the 
calcium/reference measuring circuit is amplified and presented to the computer 
for calculation. 
Sample: plasma, serum or heparinized whole blood (If samples are to be 
analyzed within one hour of collection, heparinized whole blood or plasma are 
preferred). 
Sample Size: 350 ul 
Reagents: None 
Equipment: Nova 2 Ionized Calcium Analyzer 
Special Procedures and Comments: 
1. Samples for ionized calcium analyses must be collected and kept anaerobic. 
If the sample is exposed to air, some carbon dioxide loss will take place, 
elevating sample pH. Since ionized calcium varies inversely with pH, a sample 
with an artificially high pH will have a correspondingly low ionized calcium. 
2. Since the electrodes do not respond to intracellular constituents of blood, 
the instrument will give results on whole blood identical to those obtained on 
plasma from the same sample. 
Reference: Kaplan, A., Szabo, L. L, & Opheim, K. E. (Eds.). (1988). Clinical 
chemistry: interpretation and techniques. 145-350. Philadelphia: Lea & 
Febiger. 
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Test: Magnesium 
Principle: The Kodak Ektachem Clinical Chemistry Slide (Mg) contains a dry, 
multilayered analytical element coated on a clear polyester support. The assay 
is based on the reaction of magnesium with an indicator dye to form a colored 
complex. The density of the resulting colored complex is related to the 
concentration of magnesium in the sample and can be measured 
spectrophotometrically. Calcium interference is eliminated by using a scavenger 
layer containing a calcium chelator. Predilution of serum samples is not 
necessary when the analyte concentration is within the dynamic range of the 
analyzer. 
Procedure: A 10 ul drop of serum sample is deposited on the slide and evenly 
distributed by the spreading layer into the underlying layers. Solute molecules 
penetrate the scavenger layer where calcium is chelated from the sample. 
Magnesium (both free and protein-bound) from the sample then reacts with the 
formazan dye derivative in the reagent layer; the high magnesium affinity of the 
dye dissociates magnesium from binding proteins. The resulting magnesium-
dye complex causes a shift in the dye absorption maximum from 540 nm to 630 
nm. The amount of dye complex formed is proportional to the magnesium 
concentration and is measured by reflection density at 630 nm. 
Mg+Z + Ca+2 > Mg+2 + Ca-Chelator complex 
chelator 
Mg+2 + Formazan dye derivative Mg-Dye complex (abs. @ 630 nm) 
Sample: serum 
Sample Size: 10 ul 
Equipment: Ektachem 700 analyzer 
Measurement Type: endpoint 630 nm 
Special Procedures and Comments: None 
Reference: Kaplan, A., Szabo, L. L., & Opheim, K. E. (Eds.). (1988). Clinical 
chemistry: interpretation and techniques. 145-350. Philadelphia: Lea & 
Febiger. 
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Table 1-1 
The effect of training on mean arterial pressure after controlling for the effect of 
heart rate. 
ANCOVA Summary Table 
Source of Variation df SS MS F p 
Model 2 233.1 116.5 3.64 0.036 
Error 38 1217.8 32.0 
Total 40 1450.9 
Parameter Estimate SE t p 
Intercept 72.02 6.76 10.65 0.0001 
Group* -2.82 2.07 -1.36 0.182 
Heart rate 0.12 0.10 1.28 0.208 
* - Members of the untrained group were given a value of zero (0) and 
members of the trained group were given a value of one (1). 
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Table I-2 
The effect of training on systolic blood pressure after controlling for the effect of 
heart rate. 
ANCOVA Summary Table 
Source of Variation df SS MS F p 
Model 2 141.6 70.8 1.24 0.301 
Error 38 2172.1 57.2 
Total 40 2313.7 
Parameter Estimate SE t p 
Intercept 105.82 9.03 11.71 0.0001 
Group* -2.49 2.77 -0.90 0.374 
Heart rate 0.08 0.13 0.63 0.530 
* - Members of the untrained group were given a value of zero (0) and 
members of the trained group were given a value of one (1). 
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Table I-3 
The effect of training on diastolic blood pressure after controlling for the effect of 
heart rate. 
ANCOVA Summary Table 
Source of Variation df SS MS F p 
Model 2 562.6 281.3 7.34 0.002 
Error 38 1455.6 38.3 
Total 40 2018.3 
Parameter Estimate SE t p 
Intercept 61.47 7.40 8.31 0.0001 
Group* -5.96 2.27 -2.63 0.012 
Heart rate 0.11 0.11 1.01 0.320 
* - Members of the untrained group were given a value of zero (0) and 
members of the trained group were given a value of one (1). 
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Table I-4 
The effect of training on serum total calcium concentration after controlling for 
the effect of serum albumin concentration. 
ANCOVA Summary Table 
Source of Variation df SS MS F P 
Model 2 1.90 0.95 7.41 0.002 
Error 38 4.87 0.13 
Total 40 6.76 
Parameter Estimate SE t P 
Intercept 7.34 0.70 10.53 0.0001 
Group* -0.01 0.15 -0.07 0.488 
Serum Albumin 0.49 0.17 2.99 0.005 
* - Members of the untrained group were given a value of zero (0) and 
members of the trained group were given a value of one (1). 
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Table I-5 
The effect of training on platelet ionized calcium concentration after controlling 
for the effect of serum albumin concentration. 
ANCOVA Summary Table 
Source of Variation df SS MS F p 
Model 2 0.011 0.005 6.43 0.004 
Error 38 0.032 0.001 
Total 40 0.043 
Parameter Estimate SE t p 
Intercept -0.013 0.057 -0.236 0.814 
Group* 0.006 0.012 0.481 0.633 
Serum Albumin 0.032 0.013 2.411 0.021 
* - Members of the untrained group were given a value of zero (0) and 
members of the trained group were given a value of one (1). 
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Table I-6 
The effect of training on serum ionized calcium concentration after controlling for 
the effect of serum albumin concentration. 
ANCOVA Summary Table 
Source of Variation df SS MS F P 
Model 2 0.94 0.47 14.19 0.00003 
Error 38 1.26 0.33 
Total 40 2.21 
Parameter Estimate SE t P 
Intercept 5.76 0.36 16.20 0.0001 
Group* -0.22 0.07 -3.00 0.005 
Serum Albumin -0.12 0.08 -1.44 0.158 
* - Members of the untrained group were given a value of zero (0) and 
members of the trained group were given a value of one (1). 
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Table I-7 
The effect of training on serum ionized calcium concentration after controlling for 
the effect of serum albumin and total protein concentrations. 
ANCOVA Summary Table 
Source of Variation df SS MS F P 
Model 3 0.95 0.32 9.35 0.0001 
Error 37 1.25 0.03 
Total 40 2.21 
Parameter Estimate SE t P 
Intercept 5.61 0.47 11.94 0.0001 
Group* -0.23 0.08 -3.00 0.005 
Serum Albumin -0.13 0.09 -1.51 0.141 
Serum Total Protein 0.03 0.06 0.50 0.622 
* - Members of the untrained group were given a value of zero (0) and 
members of the trained group were given a value of one (1). 
